<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37286535</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>09</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2059-3635</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>07</Day></PubDate></JournalIssue><Title>Signal transduction and targeted therapy</Title><ISOAbbreviation>Signal Transduct Target Ther</ISOAbbreviation></Journal><ArticleTitle>Metabolic alterations upon SARS-CoV-2 infection and potential therapeutic targets against coronavirus infection.</ArticleTitle><Pagination><StartPage>237</StartPage><MedlinePgn>237</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">237</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41392-023-01510-8</ELocationID><Abstract><AbstractText>The coronavirus disease 2019 (COVID-19) caused by coronavirus SARS-CoV-2 infection has become a global pandemic due to the high viral transmissibility and pathogenesis, bringing enormous burden to our society. Most patients infected by SARS-CoV-2 are asymptomatic or have mild symptoms. Although only a small proportion of patients progressed to severe COVID-19 with symptoms including acute respiratory distress syndrome (ARDS), disseminated coagulopathy, and cardiovascular disorders, severe COVID-19 is accompanied by high mortality rates with near 7 million deaths. Nowadays, effective therapeutic patterns for severe COVID-19 are still lacking. It has been extensively reported that host metabolism plays essential roles in various physiological processes during virus infection. Many viruses manipulate host metabolism to avoid immunity, facilitate their own replication, or to initiate pathological response. Targeting the interaction between SARS-CoV-2 and host metabolism holds promise for developing therapeutic strategies. In this review, we summarize and discuss recent studies dedicated to uncovering the role of host metabolism during the life cycle of SARS-CoV-2 in aspects of entry, replication, assembly, and pathogenesis with an emphasis on glucose metabolism and lipid metabolism. Microbiota and long COVID-19 are also discussed. Ultimately, we recapitulate metabolism-modulating drugs repurposed for COVID-19 including statins, ASM inhibitors, NSAIDs, Montelukast, omega-3 fatty acids, 2-DG, and metformin.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Peiran</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-4367-5468</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, City University of Hong Kong, HKSAR, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Mandi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, City University of Hong Kong, HKSAR, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Yaqing</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Shenzhen Center for Disease Control and Prevention, Shenzhen, 518055, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Binghua</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Cell Signaling and Proteomic Center, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Ming-Liang</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, City University of Hong Kong, HKSAR, Hong Kong, China. minglihe@cityu.edu.hk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Signal Transduct Target Ther</MedlineTA><NlmUniqueID>101676423</NlmUniqueID><ISSNLinking>2059-3635</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050356" MajorTopicYN="N">Lipid Metabolism</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>8</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>7</Day><Hour>23</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>7</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37286535</ArticleId><ArticleId IdType="pmc">PMC10244875</ArticleId><ArticleId IdType="doi">10.1038/s41392-023-01510-8</ArticleId><ArticleId IdType="pii">10.1038/s41392-023-01510-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>He M-L, et al. Kinetics and synergistic effects of siRNAs targeting structural and replicase genes of SARS-associated coronavirus. Febs. Lett. 2006;580:2414&#x2013;2420. doi: 10.1016/j.febslet.2006.03.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2006.03.066</ArticleId><ArticleId IdType="pmc">PMC7094648</ArticleId><ArticleId IdType="pubmed">16638566</ArticleId></ArticleIdList></Reference><Reference><Citation>de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat. Rev. Microbiol. 2016;14:523&#x2013;534. doi: 10.1038/nrmicro.2016.81.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro.2016.81</ArticleId><ArticleId IdType="pmc">PMC7097822</ArticleId><ArticleId IdType="pubmed">27344959</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison AG, Lin T, Wang P. Mechanisms of SARS-CoV-2 transmission and pathogenesis. Trends Immunol. 2020;41:1100&#x2013;1115. doi: 10.1016/j.it.2020.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2020.10.004</ArticleId><ArticleId IdType="pmc">PMC7556779</ArticleId><ArticleId IdType="pubmed">33132005</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265&#x2013;269. doi: 10.1038/s41586-020-2008-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2008-3</ArticleId><ArticleId IdType="pmc">PMC7094943</ArticleId><ArticleId IdType="pubmed">32015508</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu R, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565&#x2013;574. doi: 10.1016/S0140-6736(20)30251-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30251-8</ArticleId><ArticleId IdType="pmc">PMC7159086</ArticleId><ArticleId IdType="pubmed">32007145</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507&#x2013;513. doi: 10.1016/S0140-6736(20)30211-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30211-7</ArticleId><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054&#x2013;1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan W, He B, Wang X, He ML. Pandemic COVID-19: current status and challenges of antiviral therapies. Genes Dis. 2020;7:502&#x2013;519. doi: 10.1016/j.gendis.2020.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gendis.2020.07.001</ArticleId><ArticleId IdType="pmc">PMC7340039</ArticleId><ArticleId IdType="pubmed">32837984</ArticleId></ArticleIdList></Reference><Reference><Citation>Masters PS. The molecular biology of Coronaviruses. Adv. Virus Res. 2006;66:193&#x2013;292. doi: 10.1016/S0065-3527(06)66005-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0065-3527(06)66005-3</ArticleId><ArticleId IdType="pmc">PMC7112330</ArticleId><ArticleId IdType="pubmed">16877062</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlman S, Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nat. Rev. Microbiol. 2009;7:439&#x2013;450. doi: 10.1038/nrmicro2147.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro2147</ArticleId><ArticleId IdType="pmc">PMC2830095</ArticleId><ArticleId IdType="pubmed">19430490</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, et al. Attenuating innate immunity and facilitating beta-coronavirus infection by NSP1 of SARS-CoV-2 through specific redistributing hnRNP A2/B1 cellular localization. Signal Transduct. Target. Ther. 2021;6:371. doi: 10.1038/s41392-021-00786-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00786-y</ArticleId><ArticleId IdType="pmc">PMC8546379</ArticleId><ArticleId IdType="pubmed">34702797</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H, Rao Z. Structural biology of SARS-CoV-2 and implications for therapeutic development. Nat. Rev. Microbiol. 2021;19:685&#x2013;700. doi: 10.1038/s41579-021-00630-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-021-00630-8</ArticleId><ArticleId IdType="pmc">PMC8447893</ArticleId><ArticleId IdType="pubmed">34535791</ArticleId></ArticleIdList></Reference><Reference><Citation>Tortorici MA, Veesler D. Structural insights into coronavirus entry. Adv. Virus Res. 2019;105:93&#x2013;116. doi: 10.1016/bs.aivir.2019.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.aivir.2019.08.002</ArticleId><ArticleId IdType="pmc">PMC7112261</ArticleId><ArticleId IdType="pubmed">31522710</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruch TR, Machamer CE. The coronavirus E protein: assembly and beyond. Viruses. 2012;4:363&#x2013;382. doi: 10.3390/v4030363.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v4030363</ArticleId><ArticleId IdType="pmc">PMC3347032</ArticleId><ArticleId IdType="pubmed">22590676</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#x2019;Kovski P, Kratzel A, Steiner S, Stalder H, Thiel V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat. Rev. Microbiol. 2021;19:155&#x2013;170. doi: 10.1038/s41579-020-00468-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00468-6</ArticleId><ArticleId IdType="pmc">PMC7592455</ArticleId><ArticleId IdType="pubmed">33116300</ArticleId></ArticleIdList></Reference><Reference><Citation>Satarker S, Nampoothiri M. Structural proteins in severe acute respiratory syndrome coronavirus-2. Arch. Med. Res. 2020;51:482&#x2013;491. doi: 10.1016/j.arcmed.2020.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2020.05.012</ArticleId><ArticleId IdType="pmc">PMC7247499</ArticleId><ArticleId IdType="pubmed">32493627</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherer KM, et al. SARS-CoV-2 nucleocapsid protein adheres to replication organelles before viral assembly at the Golgi/ERGIC and lysosome-mediated egress. Sci. Adv. 2022;8:eabl4895. doi: 10.1126/sciadv.abl4895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abl4895</ArticleId><ArticleId IdType="pmc">PMC10954198</ArticleId><ArticleId IdType="pubmed">34995113</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu X, Pan J, Tao J, Guo D. SARS-CoV nucleocapsid protein antagonizes IFN-beta response by targeting initial step of IFN-beta induction pathway, and its C-terminal region is critical for the antagonism. Virus Genes. 2011;42:37&#x2013;45. doi: 10.1007/s11262-010-0544-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11262-010-0544-x</ArticleId><ArticleId IdType="pmc">PMC7088804</ArticleId><ArticleId IdType="pubmed">20976535</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F. Structure, function, and evolution of coronavirus spike proteins. Annu. Rev. Virol. 2016;3:237&#x2013;261. doi: 10.1146/annurev-virology-110615-042301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-virology-110615-042301</ArticleId><ArticleId IdType="pmc">PMC5457962</ArticleId><ArticleId IdType="pubmed">27578435</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Brey I, Bartenschlager R. Membranous replication factories induced by plus-strand RNA viruses. Viruses. 2014;6:2826&#x2013;2857. doi: 10.3390/v6072826.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v6072826</ArticleId><ArticleId IdType="pmc">PMC4113795</ArticleId><ArticleId IdType="pubmed">25054883</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller S, Krijnse-Locker J. Modification of intracellular membrane structures for virus replication. Nat. Rev. Microbiol. 2008;6:363&#x2013;374. doi: 10.1038/nrmicro1890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro1890</ArticleId><ArticleId IdType="pmc">PMC7096853</ArticleId><ArticleId IdType="pubmed">18414501</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortese M, et al. Integrative imaging reveals SARS-CoV-2-induced reshaping of subcellular morphologies. Cell Host Microbe. 2020;28:853&#x2013;866. doi: 10.1016/j.chom.2020.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.11.003</ArticleId><ArticleId IdType="pmc">PMC7670925</ArticleId><ArticleId IdType="pubmed">33245857</ArticleId></ArticleIdList></Reference><Reference><Citation>Snijder EJ, et al. Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex. J. Virol. 2006;80:5927&#x2013;5940. doi: 10.1128/JVI.02501-05.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02501-05</ArticleId><ArticleId IdType="pmc">PMC1472606</ArticleId><ArticleId IdType="pubmed">16731931</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff G, Melia CE, Snijder EJ, Barcena M. Double-membrane vesicles as platforms for viral replication. Trends Microbiol. 2020;28:1022&#x2013;1033. doi: 10.1016/j.tim.2020.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2020.05.009</ArticleId><ArticleId IdType="pmc">PMC7289118</ArticleId><ArticleId IdType="pubmed">32536523</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff G, et al. A molecular pore spans the double membrane of the coronavirus replication organelle. Science. 2020;369:1395. doi: 10.1126/science.abd3629.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd3629</ArticleId><ArticleId IdType="pmc">PMC7665310</ArticleId><ArticleId IdType="pubmed">32763915</ArticleId></ArticleIdList></Reference><Reference><Citation>de Haan CAM, Rottier PJM. Molecular interactions in the assembly of coronaviruses. Adv. Virus Res. 2005;64:165&#x2013;230. doi: 10.1016/S0065-3527(05)64006-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0065-3527(05)64006-7</ArticleId><ArticleId IdType="pmc">PMC7112327</ArticleId><ArticleId IdType="pubmed">16139595</ArticleId></ArticleIdList></Reference><Reference><Citation>Stertz S, et al. The intracellular sites of early replication and budding of SARS-coronavirus. Virology. 2007;361:304&#x2013;315. doi: 10.1016/j.virol.2006.11.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2006.11.027</ArticleId><ArticleId IdType="pmc">PMC7103305</ArticleId><ArticleId IdType="pubmed">17210170</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh S, et al. beta-Coronaviruses use lysosomes for egress instead of the biosynthetic secretory pathway. Cell. 2020;183:1520&#x2013;1535.e1514. doi: 10.1016/j.cell.2020.10.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.039</ArticleId><ArticleId IdType="pmc">PMC7590812</ArticleId><ArticleId IdType="pubmed">33157038</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendonca, L. et al. SARS-CoV-2 assembly and egress pathway revealed by correlative multi-modal multi-scale cryo-imaging. Preprint at bioRxiv10.1101/2020.11.05.370239 (2020).</Citation></Reference><Reference><Citation>Strating JR, van Kuppeveld FJ. Viral rewiring of cellular lipid metabolism to create membranous replication compartments. Curr. Opin. Cell Biol. 2017;47:24&#x2013;33. doi: 10.1016/j.ceb.2017.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceb.2017.02.005</ArticleId><ArticleId IdType="pmc">PMC7127510</ArticleId><ArticleId IdType="pubmed">28242560</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Acebes MA, Vazquez-Calvo A, Saiz JC. Lipids and flaviviruses, present and future perspectives for the control of dengue, Zika, and West Nile viruses. Prog. Lipid Res. 2016;64:123&#x2013;137. doi: 10.1016/j.plipres.2016.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.plipres.2016.09.005</ArticleId><ArticleId IdType="pubmed">27702593</ArticleId></ArticleIdList></Reference><Reference><Citation>Blaising J, Pecheur EI. Lipids: a key for hepatitis C virus entry and a potential target for antiviral strategies. Biochimie. 2013;95:96&#x2013;102. doi: 10.1016/j.biochi.2012.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2012.07.016</ArticleId><ArticleId IdType="pubmed">22884392</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan RB, Tanner L, Wenk MR. Implications for lipids during replication of enveloped viruses. Chem. Phys. Lipids. 2010;163:449&#x2013;459. doi: 10.1016/j.chemphyslip.2010.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chemphyslip.2010.03.002</ArticleId><ArticleId IdType="pmc">PMC7124286</ArticleId><ArticleId IdType="pubmed">20230810</ArticleId></ArticleIdList></Reference><Reference><Citation>Altan-Bonnet N. Lipid tales of viral replication and transmission. Trends Cell Biol. 2017;27:201&#x2013;213. doi: 10.1016/j.tcb.2016.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2016.09.011</ArticleId><ArticleId IdType="pmc">PMC5318230</ArticleId><ArticleId IdType="pubmed">27838086</ArticleId></ArticleIdList></Reference><Reference><Citation>Monson EA, Trenerry AM, Laws JL, Mackenzie JM, Helbig KJ. Lipid droplets and lipid mediators in viral infection and immunity. Fems. Microbiol. Rev. 2021;45:fuaa066. doi: 10.1093/femsre/fuaa066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/femsre/fuaa066</ArticleId><ArticleId IdType="pmc">PMC8371277</ArticleId><ArticleId IdType="pubmed">33512504</ArticleId></ArticleIdList></Reference><Reference><Citation>Monson EA, Whelan DR, Helbig KJ. Lipid droplet motility increases following viral immune stimulation. Int. J. Mol. Sci. 2021;22:4418. doi: 10.3390/ijms22094418.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22094418</ArticleId><ArticleId IdType="pmc">PMC8122965</ArticleId><ArticleId IdType="pubmed">33922664</ArticleId></ArticleIdList></Reference><Reference><Citation>Grootemaat AE, et al. Lipid and nucleocapsid N-protein accumulation in COVID-19 patient. Microbiol. Spectr. 2022;10:e01271&#x2013;21. doi: 10.1128/spectrum.01271-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.01271-21</ArticleId><ArticleId IdType="pmc">PMC8849100</ArticleId><ArticleId IdType="pubmed">35171025</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardacci R, et al. Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis. Cell Death Dis. 2021;12:263. doi: 10.1038/s41419-021-03527-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-021-03527-9</ArticleId><ArticleId IdType="pmc">PMC7952828</ArticleId><ArticleId IdType="pubmed">33712574</ArticleId></ArticleIdList></Reference><Reference><Citation>Song JW, et al. Omics-driven systems interrogation of metabolic dysregulation in COVID-19 pathogenesis. Cell Metab. 2020;32:188&#x2013;202.e185. doi: 10.1016/j.cmet.2020.06.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.06.016</ArticleId><ArticleId IdType="pmc">PMC7311890</ArticleId><ArticleId IdType="pubmed">32610096</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D, et al. Plasma metabolomic and lipidomic alterations associated with COVID-19. Natl Sci. Rev. 2020;7:1157&#x2013;1168. doi: 10.1093/nsr/nwaa086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nsr/nwaa086</ArticleId><ArticleId IdType="pmc">PMC7197563</ArticleId><ArticleId IdType="pubmed">34676128</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunt SY, Vander Heiden MG. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu. Rev. Cell. Dev. Biol. 2011;27:441&#x2013;464. doi: 10.1146/annurev-cellbio-092910-154237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-cellbio-092910-154237</ArticleId><ArticleId IdType="pubmed">21985671</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L, Zhao Q, Yang T, Ding W, Zhao Y. Cellular metabolism and macrophage functional polarization. Int. Rev. Immunol. 2015;34:82&#x2013;100. doi: 10.3109/08830185.2014.969421.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08830185.2014.969421</ArticleId><ArticleId IdType="pubmed">25340307</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee AH, Dixit VD. Dietary regulation of immunity. Immunity. 2020;53:510&#x2013;523. doi: 10.1016/j.immuni.2020.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.08.013</ArticleId><ArticleId IdType="pmc">PMC7491384</ArticleId><ArticleId IdType="pubmed">32937152</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang S, Tang H. HIV-1 infection and glucose metabolism reprogramming of T cells: another approach toward functional cure and reservoir eradication. Front. Immunol. 2020;11:572677. doi: 10.3389/fimmu.2020.572677.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.572677</ArticleId><ArticleId IdType="pmc">PMC7575757</ArticleId><ArticleId IdType="pubmed">33117366</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Bossche J, O&#x2019;Neill LA, Menon D. Macrophage immunometabolism: where are we going? Trends Immunol. 2017;38:395&#x2013;406. doi: 10.1016/j.it.2017.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2017.03.001</ArticleId><ArticleId IdType="pubmed">28396078</ArticleId></ArticleIdList></Reference><Reference><Citation>Willig AL, Overton ET. Metabolic complications and glucose metabolism in HIV infection: a review of the evidence. Curr. HIV/AIDS Rep. 2016;13:289&#x2013;296. doi: 10.1007/s11904-016-0330-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11904-016-0330-z</ArticleId><ArticleId IdType="pmc">PMC5425100</ArticleId><ArticleId IdType="pubmed">27541600</ArticleId></ArticleIdList></Reference><Reference><Citation>Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029&#x2013;1033. doi: 10.1126/science.1160809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1160809</ArticleId><ArticleId IdType="pmc">PMC2849637</ArticleId><ArticleId IdType="pubmed">19460998</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim S, Bae JH, Kwon HS, Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat. Rev. Endocrinol. 2021;17:11&#x2013;30. doi: 10.1038/s41574-020-00435-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-020-00435-4</ArticleId><ArticleId IdType="pmc">PMC7664589</ArticleId><ArticleId IdType="pubmed">33188364</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson EJ, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:430&#x2013;436. doi: 10.1038/s41586-020-2521-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2521-4</ArticleId><ArticleId IdType="pmc">PMC7611074</ArticleId><ArticleId IdType="pubmed">32640463</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L, et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell metab. 2020;31:1068&#x2013;1077.e1063. doi: 10.1016/j.cmet.2020.04.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.04.021</ArticleId><ArticleId IdType="pmc">PMC7252168</ArticleId><ArticleId IdType="pubmed">32369736</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Q, et al. Metabolic modeling of single bronchoalveolar macrophages reveals regulators of hyperinflammation in COVID-19. iScience. 2022;25:105319. doi: 10.1016/j.isci.2022.105319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.105319</ArticleId><ArticleId IdType="pmc">PMC9549388</ArticleId><ArticleId IdType="pubmed">36246577</ArticleId></ArticleIdList></Reference><Reference><Citation>Harding JL, et al. The bidirectional association between diabetes and long-COVID-19 - A systematic review. Diabetes Res. Clin. Pract. 2022;195:110202. doi: 10.1016/j.diabres.2022.110202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabres.2022.110202</ArticleId><ArticleId IdType="pmc">PMC9727969</ArticleId><ArticleId IdType="pubmed">36496030</ArticleId></ArticleIdList></Reference><Reference><Citation>Rey-Renones C, et al. Type 2 diabetes mellitus and COVID-19: a narrative review. Biomedicines. 2022;10:2089. doi: 10.3390/biomedicines10092089.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10092089</ArticleId><ArticleId IdType="pmc">PMC9495673</ArticleId><ArticleId IdType="pubmed">36140191</ArticleId></ArticleIdList></Reference><Reference><Citation>Gusev E, Sarapultsev A, Solomatina L, Chereshnev V. SARS-CoV-2-specific immune response and the pathogenesis of COVID-19. Int. J. Mol. Sci. 2022;23:1716. doi: 10.3390/ijms23031716.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23031716</ArticleId><ArticleId IdType="pmc">PMC8835786</ArticleId><ArticleId IdType="pubmed">35163638</ArticleId></ArticleIdList></Reference><Reference><Citation>Amraei R, et al. CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2. Acs. Cent. Sci. 2021;7:1156&#x2013;1165. doi: 10.1021/acscentsci.0c01537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acscentsci.0c01537</ArticleId><ArticleId IdType="pmc">PMC8265543</ArticleId><ArticleId IdType="pubmed">34341769</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, et al. AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells. Cell Res. 2021;31:126&#x2013;140. doi: 10.1038/s41422-020-00460-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-020-00460-y</ArticleId><ArticleId IdType="pmc">PMC7791157</ArticleId><ArticleId IdType="pubmed">33420426</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch J, et al. TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cells. EMBO J. 2021;40:e107821. doi: 10.15252/embj.2021107821.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2021107821</ArticleId><ArticleId IdType="pmc">PMC8365257</ArticleId><ArticleId IdType="pubmed">34159616</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271&#x2013;280. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Beumer J, et al. A CRISPR/Cas9 genetically engineered organoid biobank reveals essential host factors for coronaviruses. Nat. Commun. 2021;12:5498. doi: 10.1038/s41467-021-25729-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25729-7</ArticleId><ArticleId IdType="pmc">PMC8448725</ArticleId><ArticleId IdType="pubmed">34535662</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn JH, Li W, Choe H, Farzan M. Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus. Cell Mol. Life. Sci. 2004;61:2738&#x2013;2743. doi: 10.1007/s00018-004-4242-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-004-4242-5</ArticleId><ArticleId IdType="pmc">PMC7079798</ArticleId><ArticleId IdType="pubmed">15549175</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou T, et al. Cryo-EM structures of SARS-CoV-2 spike without and with ACE2 reveal a pH-dependent switch to mediate endosomal positioning of receptor-binding domains. Cell Host Microbe. 2020;28:867&#x2013;879.e865. doi: 10.1016/j.chom.2020.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.11.004</ArticleId><ArticleId IdType="pmc">PMC7670890</ArticleId><ArticleId IdType="pubmed">33271067</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei J, et al. Genome-wide CRISPR screens reveal host factors critical for SARS-CoV-2 infection. Cell. 2021;184:76&#x2013;91.e13. doi: 10.1016/j.cell.2020.10.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.028</ArticleId><ArticleId IdType="pmc">PMC7574718</ArticleId><ArticleId IdType="pubmed">33147444</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayati A, Kumar R, Francis V, McPherson PS. SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis. J. Biol. Chem. 2021;296:100306. doi: 10.1016/j.jbc.2021.100306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2021.100306</ArticleId><ArticleId IdType="pmc">PMC7816624</ArticleId><ArticleId IdType="pubmed">33476648</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat. Rev. Mol. Cell Biol. 2022;23:3&#x2013;20. doi: 10.1038/s41580-021-00418-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00418-x</ArticleId><ArticleId IdType="pmc">PMC8491763</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Simons K, Sampaio JL. Membrane organization and lipid rafts. Cold Spring Harb. Perspect. Biol. 2011;3:a004697. doi: 10.1101/cshperspect.a004697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a004697</ArticleId><ArticleId IdType="pmc">PMC3179338</ArticleId><ArticleId IdType="pubmed">21628426</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorice M, et al. Targeting lipid rafts as a strategy against coronavirus. Front. Cell. Dev. Biol. 2020;8:618296. doi: 10.3389/fcell.2020.618296.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.618296</ArticleId><ArticleId IdType="pmc">PMC7890255</ArticleId><ArticleId IdType="pubmed">33614627</ArticleId></ArticleIdList></Reference><Reference><Citation>Fecchi K, et al. Coronavirus interplay with lipid rafts and autophagy unveils promising therapeutic targets. Front. Microbiol. 2020;11:1821. doi: 10.3389/fmicb.2020.01821.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.01821</ArticleId><ArticleId IdType="pmc">PMC7431668</ArticleId><ArticleId IdType="pubmed">32849425</ArticleId></ArticleIdList></Reference><Reference><Citation>Peruzzu D, et al. Zika virus exploits lipid rafts to infect host cells. Viruses. 2022;14:2059. doi: 10.3390/v14092059.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14092059</ArticleId><ArticleId IdType="pmc">PMC9506595</ArticleId><ArticleId IdType="pubmed">36146865</ArticleId></ArticleIdList></Reference><Reference><Citation>Palacios-Rapalo SN, et al. Cholesterol-rich lipid rafts as platforms for SARS-CoV-2 entry. Front. Immunol. 2021;12:796855. doi: 10.3389/fimmu.2021.796855.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.796855</ArticleId><ArticleId IdType="pmc">PMC8719300</ArticleId><ArticleId IdType="pubmed">34975904</ArticleId></ArticleIdList></Reference><Reference><Citation>Glende J, et al. Importance of cholesterol-rich membrane microdomains in the interaction of the S protein of SARS-coronavirus with the cellular receptor angiotensin-converting enzyme 2. Virology. 2008;381:215&#x2013;221. doi: 10.1016/j.virol.2008.08.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2008.08.026</ArticleId><ArticleId IdType="pmc">PMC7103374</ArticleId><ArticleId IdType="pubmed">18814896</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Liu DX, Tam JP. Lipid rafts are involved in SARS-CoV entry into Vero E6 cells. Biochem. Biophys. Res. Commun. 2008;369:344&#x2013;349. doi: 10.1016/j.bbrc.2008.02.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2008.02.023</ArticleId><ArticleId IdType="pmc">PMC7092920</ArticleId><ArticleId IdType="pubmed">18279660</ArticleId></ArticleIdList></Reference><Reference><Citation>Warner FJ, et al. Angiotensin-converting enzyme 2 (ACE2), but not ACE, is preferentially localized to the apical surface of polarized kidney cells. J. Biol. Chem. 2005;280:39353&#x2013;39362. doi: 10.1074/jbc.M508914200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M508914200</ArticleId><ArticleId IdType="pubmed">16166094</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim JR, et al. Amelioration of SARS-CoV-2 infection by ANO6 phospholipid scramblase inhibition. Cell Rep. 2022;40:111117. doi: 10.1016/j.celrep.2022.111117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2022.111117</ArticleId><ArticleId IdType="pmc">PMC9250890</ArticleId><ArticleId IdType="pubmed">35839776</ArticleId></ArticleIdList></Reference><Reference><Citation>George KS, Wu S. Lipid raft: a floating island of death or survival. Toxicol. Appl. Pharmacol. 2012;259:311&#x2013;319. doi: 10.1016/j.taap.2012.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.taap.2012.01.007</ArticleId><ArticleId IdType="pmc">PMC3299927</ArticleId><ArticleId IdType="pubmed">22289360</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, et al. Dependence of SARS-CoV-2 infection on cholesterol-rich lipid raft and endosomal acidification. Comput. Struct. Biotechnol. J. 2021;19:1933&#x2013;1943. doi: 10.1016/j.csbj.2021.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.csbj.2021.04.001</ArticleId><ArticleId IdType="pmc">PMC8028701</ArticleId><ArticleId IdType="pubmed">33850607</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, et al. Cholesterol 25-Hydroxylase inhibits SARS-CoV-2 and other coronaviruses by depleting membrane cholesterol. EMBO J. 2020;39:e106057. doi: 10.15252/embj.2020106057.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020106057</ArticleId><ArticleId IdType="pmc">PMC7537045</ArticleId><ArticleId IdType="pubmed">32944968</ArticleId></ArticleIdList></Reference><Reference><Citation>Compton AA, Schwartz O. They might be giants: does syncytium formation sink or spread HIV infection? PLoS. Pathog. 2017;13:e1006099. doi: 10.1371/journal.ppat.1006099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006099</ArticleId><ArticleId IdType="pmc">PMC5289631</ArticleId><ArticleId IdType="pubmed">28152024</ArticleId></ArticleIdList></Reference><Reference><Citation>Duelli D, Lazebnik Y. Cell-to-cell fusion as a link between viruses and Cancer. Nat. Rev. Cancer. 2007;7:968&#x2013;976. doi: 10.1038/nrc2272.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc2272</ArticleId><ArticleId IdType="pubmed">18034186</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchrieser J, et al. Syncytia formation by SARS-CoV-2-infected cells. EMBO J. 2020;39:e106267. doi: 10.15252/embj.2020106267.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020106267</ArticleId><ArticleId IdType="pmc">PMC7646020</ArticleId><ArticleId IdType="pubmed">33051876</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders DW, et al. SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation. eLife. 2021;10:e65962. doi: 10.7554/eLife.65962.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.65962</ArticleId><ArticleId IdType="pmc">PMC8104966</ArticleId><ArticleId IdType="pubmed">33890572</ArticleId></ArticleIdList></Reference><Reference><Citation>Musarrat F, et al. The anti-HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV-2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID-19 infections. J. Med. Virol. 2020;92:2087&#x2013;2095. doi: 10.1002/jmv.25985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25985</ArticleId><ArticleId IdType="pmc">PMC7267418</ArticleId><ArticleId IdType="pubmed">32374457</ArticleId></ArticleIdList></Reference><Reference><Citation>Niyogi K, Hildreth JE. Characterization of new syncytium-inhibiting monoclonal antibodies implicates lipid rafts in human T-cell leukemia virus type 1 syncytium formation. J. Virol. 2001;75:7351&#x2013;7361. doi: 10.1128/JVI.75.16.7351-7361.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.75.16.7351-7361.2001</ArticleId><ArticleId IdType="pmc">PMC114970</ArticleId><ArticleId IdType="pubmed">11462007</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei C, et al. HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry. Nat. Metab. 2020;2:1391&#x2013;1400. doi: 10.1038/s42255-020-00324-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-020-00324-0</ArticleId><ArticleId IdType="pubmed">33244168</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen WJ, Asthana S, Kraemer FB, Azhar S. Scavenger receptor B type 1: expression, molecular regulation, and cholesterol transport function. J. Lipid Res. 2018;59:1114&#x2013;1131. doi: 10.1194/jlr.R083121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.R083121</ArticleId><ArticleId IdType="pmc">PMC6027903</ArticleId><ArticleId IdType="pubmed">29720388</ArticleId></ArticleIdList></Reference><Reference><Citation>Correa Y, et al. SARS-CoV-2 spike protein removes lipids from model membranes and interferes with the capacity of high density lipoprotein to exchange lipids. J. Colloid Interface Sci. 2021;602:732&#x2013;739. doi: 10.1016/j.jcis.2021.06.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcis.2021.06.056</ArticleId><ArticleId IdType="pmc">PMC8195693</ArticleId><ArticleId IdType="pubmed">34157514</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R, et al. Genetic screens identify host factors for SARS-CoV-2 and common cold coronaviruses. Cell. 2021;184:106&#x2013;119.e114. doi: 10.1016/j.cell.2020.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.12.004</ArticleId><ArticleId IdType="pmc">PMC7723770</ArticleId><ArticleId IdType="pubmed">33333024</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniloski Z, et al. Identification of required host factors for SARS-CoV-2 infection in human. Cells Cell. 2021;184:92&#x2013;105.e116. doi: 10.1016/j.cell.2020.10.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.030</ArticleId><ArticleId IdType="pmc">PMC7584921</ArticleId><ArticleId IdType="pubmed">33147445</ArticleId></ArticleIdList></Reference><Reference><Citation>Campanero-Rhodes MA, et al. N-glycolyl GM1 ganglioside as a receptor for simian virus 40. J. Virol. 2007;81:12846&#x2013;12858. doi: 10.1128/JVI.01311-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01311-07</ArticleId><ArticleId IdType="pmc">PMC2169104</ArticleId><ArticleId IdType="pubmed">17855525</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller ME, Adhikary S, Kolokoltsov AA, Davey RA. Ebolavirus requires acid sphingomyelinase activity and plasma membrane sphingomyelin for infection. J. Virol. 2012;86:7473&#x2013;7483. doi: 10.1128/JVI.00136-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00136-12</ArticleId><ArticleId IdType="pmc">PMC3416309</ArticleId><ArticleId IdType="pubmed">22573858</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi Y, et al. Sphingomyelin synthase 2, but not sphingomyelin synthase 1, is involved in HIV-1 envelope-mediated membrane fusion. J. Biol. Chem. 2014;289:30842&#x2013;30856. doi: 10.1074/jbc.M114.574285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.574285</ArticleId><ArticleId IdType="pmc">PMC4215260</ArticleId><ArticleId IdType="pubmed">25231990</ArticleId></ArticleIdList></Reference><Reference><Citation>Aizaki H, et al. Critical role of virion-associated cholesterol and sphingolipid in hepatitis C virus infection. J. Virol. 2008;82:5715&#x2013;5724. doi: 10.1128/JVI.02530-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02530-07</ArticleId><ArticleId IdType="pmc">PMC2395132</ArticleId><ArticleId IdType="pubmed">18367533</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannun YA, Obeid LM. Sphingolipids and their metabolism in physiology and disease. Nat. Rev. Mol. Cell Biol. 2018;19:175&#x2013;191. doi: 10.1038/nrm.2017.107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm.2017.107</ArticleId><ArticleId IdType="pmc">PMC5902181</ArticleId><ArticleId IdType="pubmed">29165427</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitner EB, Avraham R, Politi B, Melamed S, Israely T. Elevation in sphingolipid upon SARS-CoV-2 infection: possible implications for COVID-19 pathology. Life Sci. Alliance. 2021;5:e202101168. doi: 10.26508/lsa.202101168.</Citation><ArticleIdList><ArticleId IdType="doi">10.26508/lsa.202101168</ArticleId><ArticleId IdType="pmc">PMC8605327</ArticleId><ArticleId IdType="pubmed">34764206</ArticleId></ArticleIdList></Reference><Reference><Citation>Torretta TE, et al. Severity of COVID-19 patients predicted by serum sphingolipids signature. Int. J. Mol. Sci. 2021;22:10198. doi: 10.3390/ijms221910198.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms221910198</ArticleId><ArticleId IdType="pmc">PMC8508132</ArticleId><ArticleId IdType="pubmed">34638539</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpinteiro A, et al. Pharmacological inhibition of acid sphingomyelinase prevents uptake of SARS-CoV-2 by epithelial cells. Cell Rep. Med. 2020;1:100142. doi: 10.1016/j.xcrm.2020.100142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2020.100142</ArticleId><ArticleId IdType="pmc">PMC7598530</ArticleId><ArticleId IdType="pubmed">33163980</ArticleId></ArticleIdList></Reference><Reference><Citation>Grassme H, et al. Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nat. Med. 2003;9:322&#x2013;330. doi: 10.1038/nm823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm823</ArticleId><ArticleId IdType="pubmed">12563314</ArticleId></ArticleIdList></Reference><Reference><Citation>Grassme H, et al. CD95 signaling via ceramide-rich membrane rafts. J. Biol. Chem. 2001;276:20589&#x2013;20596. doi: 10.1074/jbc.M101207200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M101207200</ArticleId><ArticleId IdType="pubmed">11279185</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpinteiro A, et al. Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells. J. Biol. Chem. 2021;296:100701. doi: 10.1016/j.jbc.2021.100701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2021.100701</ArticleId><ArticleId IdType="pmc">PMC8062550</ArticleId><ArticleId IdType="pubmed">33895135</ArticleId></ArticleIdList></Reference><Reference><Citation>Schloer S, et al. Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine. Emerg. Microbes Infect. 2020;9:2245&#x2013;2255. doi: 10.1080/22221751.2020.1829082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1829082</ArticleId><ArticleId IdType="pmc">PMC7594754</ArticleId><ArticleId IdType="pubmed">32975484</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards MJ, et al. Sphingosine prevents binding of SARS-CoV-2 spike to its cellular receptor ACE2. J. Biol. Chem. 2020;295:15174&#x2013;15182. doi: 10.1074/jbc.RA120.015249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA120.015249</ArticleId><ArticleId IdType="pmc">PMC7650243</ArticleId><ArticleId IdType="pubmed">32917722</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoertel N, et al. Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms. Mol. Psychiatry. 2021;26:7098&#x2013;7099. doi: 10.1038/s41380-021-01254-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-021-01254-3</ArticleId><ArticleId IdType="pmc">PMC8359627</ArticleId><ArticleId IdType="pubmed">34385600</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen L, et al. Sialic acid-containing glycolipids mediate binding and viral entry of SARS-CoV-2. Nat. Chem. Biol. 2022;18:81&#x2013;90. doi: 10.1038/s41589-021-00924-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41589-021-00924-1</ArticleId><ArticleId IdType="pubmed">34754101</ArticleId></ArticleIdList></Reference><Reference><Citation>Fantini J, Di Scala C, Chahinian H, Yahi N. Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection. Int. J. Antimicrob. Agents. 2020;55:105960. doi: 10.1016/j.ijantimicag.2020.105960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2020.105960</ArticleId><ArticleId IdType="pmc">PMC7128678</ArticleId><ArticleId IdType="pubmed">32251731</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan, Z., Pavel, M. A., Wang, H. &amp; Hansen, S. B. Hydroxychloroquine: mechanism of action inhibiting SARS-CoV2 entry. Preprint at bioRxiv10.1101/2020.08.13.250217 (2020).</Citation></Reference><Reference><Citation>Al-Bari MA. Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases. J. Antimicrob. Chemother. 2015;70:1608&#x2013;1621. doi: 10.1093/jac/dkv018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkv018</ArticleId><ArticleId IdType="pmc">PMC7537707</ArticleId><ArticleId IdType="pubmed">25693996</ArticleId></ArticleIdList></Reference><Reference><Citation>Pastick KA, et al. Review: hydroxychloroquine and chloroquine for treatment of SARS-CoV-2 (COVID-19) Open Forum Infect. Dis. 2020;7:ofaa130. doi: 10.1093/ofid/ofaa130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofaa130</ArticleId><ArticleId IdType="pmc">PMC7184359</ArticleId><ArticleId IdType="pubmed">32363212</ArticleId></ArticleIdList></Reference><Reference><Citation>Das S, et al. The controversial therapeutic journey of chloroquine and hydroxychloroquine in the battle against SARS-CoV-2: A comprehensive review. Med. Drug. Discov. 2021;10:100085. doi: 10.1016/j.medidd.2021.100085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medidd.2021.100085</ArticleId><ArticleId IdType="pmc">PMC8026171</ArticleId><ArticleId IdType="pubmed">33846702</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Wang Y, Qi C, Shen L, Li J. Clinical trial analysis of 2019-nCoV therapy registered in China. J. Med. Virol. 2020;92:540&#x2013;545. doi: 10.1002/jmv.25733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25733</ArticleId><ArticleId IdType="pmc">PMC7228274</ArticleId><ArticleId IdType="pubmed">32108352</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci. Trends. 2020;14:72&#x2013;73. doi: 10.5582/bst.2020.01047.</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/bst.2020.01047</ArticleId><ArticleId IdType="pubmed">32074550</ArticleId></ArticleIdList></Reference><Reference><Citation>Brevini T, et al. FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2. Nature. 2022;615:134&#x2013;142. doi: 10.1038/s41586-022-05594-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05594-0</ArticleId><ArticleId IdType="pmc">PMC9977684</ArticleId><ArticleId IdType="pubmed">36470304</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng T, et al. Glycosylation of viral proteins: Implication in virus-host interaction and virulence. Virulence. 2022;13:670&#x2013;683. doi: 10.1080/21505594.2022.2060464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2022.2060464</ArticleId><ArticleId IdType="pmc">PMC9037552</ArticleId><ArticleId IdType="pubmed">35436420</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng N, et al. Protein post-translational modification in SARS-CoV-2 and host interaction. Front. Immunol. 2022;13:1068449. doi: 10.3389/fimmu.2022.1068449.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1068449</ArticleId><ArticleId IdType="pmc">PMC9880545</ArticleId><ArticleId IdType="pubmed">36713387</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi N, Goel B, Bhardwaj N, Vishwakarma RA, Jain SK. Exploring the potential of chemical inhibitors for targeting post-translational glycosylation of coronavirus (SARS-CoV-2) ACS Omega. 2022;7:27038&#x2013;27051. doi: 10.1021/acsomega.2c02345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsomega.2c02345</ArticleId><ArticleId IdType="pmc">PMC9344791</ArticleId><ArticleId IdType="pubmed">35937682</ArticleId></ArticleIdList></Reference><Reference><Citation>Tortorici MA, et al. Structural basis for human coronavirus attachment to sialic acid receptors. Nat. Struct. Mol. Biol. 2019;26:481&#x2013;489. doi: 10.1038/s41594-019-0233-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-019-0233-y</ArticleId><ArticleId IdType="pmc">PMC6554059</ArticleId><ArticleId IdType="pubmed">31160783</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan Y, et al. Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains. Nat. Commun. 2017;8:15092. doi: 10.1038/ncomms15092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms15092</ArticleId><ArticleId IdType="pmc">PMC5394239</ArticleId><ArticleId IdType="pubmed">28393837</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrapp D, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367:1260. doi: 10.1126/science.abb2507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb2507</ArticleId><ArticleId IdType="pmc">PMC7164637</ArticleId><ArticleId IdType="pubmed">32075877</ArticleId></ArticleIdList></Reference><Reference><Citation>Benton DJ, et al. Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion. Nature. 2020;588:327&#x2013;330. doi: 10.1038/s41586-020-2772-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2772-0</ArticleId><ArticleId IdType="pmc">PMC7116727</ArticleId><ArticleId IdType="pubmed">32942285</ArticleId></ArticleIdList></Reference><Reference><Citation>Toelzer C, et al. Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein. Science. 2020;370:725. doi: 10.1126/science.abd3255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd3255</ArticleId><ArticleId IdType="pmc">PMC8050947</ArticleId><ArticleId IdType="pubmed">32958580</ArticleId></ArticleIdList></Reference><Reference><Citation>Vivar-Sierra A, et al. In silico study of polyunsaturated fatty acids as potential SARS-CoV-2 spike protein closed conformation stabilizers: epidemiological and computational approaches. Molecules. 2021;26:711. doi: 10.3390/molecules26030711.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26030711</ArticleId><ArticleId IdType="pmc">PMC7866518</ArticleId><ArticleId IdType="pubmed">33573088</ArticleId></ArticleIdList></Reference><Reference><Citation>Sofia FOA, et al. The fatty acid site is coupled to functional motifs in the SARS-CoV-2 spike protein and modulates spike allosteric behaviour. Comput. Struct. Biotechnol. J. 2021;20:139&#x2013;147. doi: 10.1016/j.csbj.2021.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.csbj.2021.12.011</ArticleId><ArticleId IdType="pmc">PMC8670790</ArticleId><ArticleId IdType="pubmed">34934478</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, et al. Protein palmitoylation modification during viral infection and detection methods of palmitoylated proteins. Front. Cell Infect. Microbiol. 2022;12:821596. doi: 10.3389/fcimb.2022.821596.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.821596</ArticleId><ArticleId IdType="pmc">PMC8829041</ArticleId><ArticleId IdType="pubmed">35155279</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdulrahman DA, Meng X, Veit M. S-Acylation of proteins of coronavirus and influenza virus: conservation of acylation sites in animal viruses and DHHC acyltransferases in their animal reservoirs. Pathogens. 2021;10:669. doi: 10.3390/pathogens10060669.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10060669</ArticleId><ArticleId IdType="pmc">PMC8227752</ArticleId><ArticleId IdType="pubmed">34072434</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, et al. Replication of murine coronavirus requires multiple cysteines in the endodomain of spike protein. Virology. 2012;427:98&#x2013;106. doi: 10.1016/j.virol.2012.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2012.02.015</ArticleId><ArticleId IdType="pmc">PMC7111998</ArticleId><ArticleId IdType="pubmed">22424735</ArticleId></ArticleIdList></Reference><Reference><Citation>Bangaru S, et al. Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate. Science. 2021;370:1089. doi: 10.1126/science.abe1502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abe1502</ArticleId><ArticleId IdType="pmc">PMC7857404</ArticleId><ArticleId IdType="pubmed">33082295</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D, Liu Y, Lu Y, Gao S, Zhang L. Palmitoylation of SARS-CoV-2 S protein is critical for S-mediated syncytia formation and virus entry. J. Med. Virol. 2022;94:342&#x2013;348. doi: 10.1002/jmv.27339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27339</ArticleId><ArticleId IdType="pmc">PMC8661603</ArticleId><ArticleId IdType="pubmed">34528721</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, et al. Palmitoylation of SARS-CoV-2 S protein is essential for viral infectivity. Signal Transduct. Target. Ther. 2021;6:231. doi: 10.1038/s41392-021-00651-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00651-y</ArticleId><ArticleId IdType="pmc">PMC8193602</ArticleId><ArticleId IdType="pubmed">34117209</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng XT, Yu XX, Cheng W. The interactions of ZDHHC5/GOLGA7 with SARS-CoV-2 spike (S) protein and their effects on S protein&#x2019;s subcellular localization, palmitoylation and pseudovirus entry. Virol. J. 2021;18:257. doi: 10.1186/s12985-021-01722-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-021-01722-w</ArticleId><ArticleId IdType="pmc">PMC8711289</ArticleId><ArticleId IdType="pubmed">34961524</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesquita FS, et al. S-acylation controls SARS-CoV-2 membrane lipid organization and enhances infectivity. Dev. Cell. 2021;56:2790&#x2013;2807.e2798. doi: 10.1016/j.devcel.2021.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2021.09.016</ArticleId><ArticleId IdType="pmc">PMC8486083</ArticleId><ArticleId IdType="pubmed">34599882</ArticleId></ArticleIdList></Reference><Reference><Citation>Petit CM, et al. Palmitoylation of the cysteine-rich endodomain of the SARS-coronavirus spike glycoprotein is important for spike-mediated cell fusion. Virology. 2007;360:264&#x2013;274. doi: 10.1016/j.virol.2006.10.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2006.10.034</ArticleId><ArticleId IdType="pmc">PMC7103323</ArticleId><ArticleId IdType="pubmed">17134730</ArticleId></ArticleIdList></Reference><Reference><Citation>McBride CE, Machamer CE. Palmitoylation of SARS-CoV S protein is necessary for partitioning into detergent-resistant membranes and cell-cell fusion but not interaction with M protein. Virology. 2010;405:139&#x2013;148. doi: 10.1016/j.virol.2010.05.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2010.05.031</ArticleId><ArticleId IdType="pmc">PMC2914208</ArticleId><ArticleId IdType="pubmed">20580052</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas-Rodriguez JR, et al. Sustained hyperglycemia and its relationship with the outcome of hospitalized patients with severe COVID-19: potential role of ACE2 upregulation. J. Pers. Med. 2022;12:805. doi: 10.3390/jpm12050805.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12050805</ArticleId><ArticleId IdType="pmc">PMC9147379</ArticleId><ArticleId IdType="pubmed">35629227</ArticleId></ArticleIdList></Reference><Reference><Citation>Wysocki J, et al. ACE and ACE2 activity in diabetic mice. Diabetes. 2006;55:2132&#x2013;2139. doi: 10.2337/db06-0033.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db06-0033</ArticleId><ArticleId IdType="pubmed">16804085</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao ST, Lau A, So HC. Exploring diseases/traits and blood proteins causally related to expression of ACE2, the putative receptor of SARS-CoV-2: a Mendelian randomization analysis highlights tentative relevance of diabetes-related traits. Diabetes Care. 2020;43:1416&#x2013;1426. doi: 10.2337/dc20-0643.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc20-0643</ArticleId><ArticleId IdType="pubmed">32430459</ArticleId></ArticleIdList></Reference><Reference><Citation>Romani-Perez M, et al. Activation of the GLP-1 receptor by liraglutide increases ACE2 expression, reversing right ventricle hypertrophy, and improving the production of SP-A and SP-B in the lungs of type 1 diabetes rats. Endocrinology. 2015;156:3559&#x2013;3569. doi: 10.1210/en.2014-1685.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2014-1685</ArticleId><ArticleId IdType="pubmed">26196539</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, et al. Pioglitazone upregulates angiotensin converting enzyme 2 expression in insulin-sensitive tissues in rats with high-fat diet-induced nonalcoholic steatohepatitis. TheScientificWorldJournal. 2014;2014:603409.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3914411</ArticleId><ArticleId IdType="pubmed">24558317</ArticleId></ArticleIdList></Reference><Reference><Citation>Wosten-van Asperen RM, et al. Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist. J. Pathol. 2011;225:618&#x2013;627. doi: 10.1002/path.2987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.2987</ArticleId><ArticleId IdType="pubmed">22009550</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrario CM, et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005;111:2605&#x2013;2610. doi: 10.1161/CIRCULATIONAHA.104.510461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.104.510461</ArticleId><ArticleId IdType="pubmed">15897343</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou X, et al. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front. Med. 2020;14:185&#x2013;192. doi: 10.1007/s11684-020-0754-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11684-020-0754-0</ArticleId><ArticleId IdType="pmc">PMC7088738</ArticleId><ArticleId IdType="pubmed">32170560</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukassen S, et al. SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells. EMBO J. 2020;39:e105114. doi: 10.15252/embj.20105114.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.20105114</ArticleId><ArticleId IdType="pmc">PMC7232010</ArticleId><ArticleId IdType="pubmed">32246845</ArticleId></ArticleIdList></Reference><Reference><Citation>Garreta E, et al. A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells. Cell Metab. 2022;34:857&#x2013;873.e859. doi: 10.1016/j.cmet.2022.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2022.04.009</ArticleId><ArticleId IdType="pmc">PMC9097013</ArticleId><ArticleId IdType="pubmed">35561674</ArticleId></ArticleIdList></Reference><Reference><Citation>Vigerust DJ, Shepherd VL. Virus glycosylation: role in virulence and immune interactions. Trends Microbiol. 2007;15:211&#x2013;218. doi: 10.1016/j.tim.2007.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2007.03.003</ArticleId><ArticleId IdType="pmc">PMC7127133</ArticleId><ArticleId IdType="pubmed">17398101</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang TJ, et al. Cryo-EM analysis of a feline coronavirus spike protein reveals a unique structure and camouflaging glycans. Proc. Natl Acad. Sci. USA. 2020;117:1438&#x2013;1446. doi: 10.1073/pnas.1908898117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1908898117</ArticleId><ArticleId IdType="pmc">PMC6983407</ArticleId><ArticleId IdType="pubmed">31900356</ArticleId></ArticleIdList></Reference><Reference><Citation>Walls AC, et al. Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy. Nat. Struct. Mol. Biol. 2016;23:899&#x2013;905. doi: 10.1038/nsmb.3293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.3293</ArticleId><ArticleId IdType="pmc">PMC5515730</ArticleId><ArticleId IdType="pubmed">27617430</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe Y, et al. Vulnerabilities in coronavirus glycan shields despite extensive glycosylation. Nat. Commun. 2020;11:2688. doi: 10.1038/s41467-020-16567-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-16567-0</ArticleId><ArticleId IdType="pmc">PMC7253482</ArticleId><ArticleId IdType="pubmed">32461612</ArticleId></ArticleIdList></Reference><Reference><Citation>Shajahan A, Supekar NT, Gleinich AS, Azadi P. Deducing the N- and O-glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2. Glycobiology. 2020;30:981&#x2013;988. doi: 10.1093/glycob/cwaa042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/glycob/cwaa042</ArticleId><ArticleId IdType="pmc">PMC7239183</ArticleId><ArticleId IdType="pubmed">32363391</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanda M, Morrison L, Goldman R. N- and O-glycosylation of the SARS-CoV-2 spike protein. Anal. Chem. 2021;93:2003&#x2013;2009. doi: 10.1021/acs.analchem.0c03173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.0c03173</ArticleId><ArticleId IdType="pmc">PMC7805595</ArticleId><ArticleId IdType="pubmed">33406838</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D, Tian X, Qi R, Peng C, Zhang W. Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: implications for vaccination and antibody therapeutics. Glycobiology. 2021;31:69&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7313968</ArticleId><ArticleId IdType="pubmed">32518941</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonopoulos A, et al. Site-specific characterization of SARS-CoV-2 spike glycoprotein receptor-binding domain. Glycobiology. 2021;31:181&#x2013;187. doi: 10.1093/glycob/cwaa085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/glycob/cwaa085</ArticleId><ArticleId IdType="pmc">PMC7499654</ArticleId><ArticleId IdType="pubmed">32886791</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe Y, et al. Site-specific glycan analysis of the SARS-CoV-2 spike. Science. 2020;369:330. doi: 10.1126/science.abb9983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb9983</ArticleId><ArticleId IdType="pmc">PMC7199903</ArticleId><ArticleId IdType="pubmed">32366695</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q, et al. The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity. Cell. 2020;182:1284&#x2013;1294.e1289. doi: 10.1016/j.cell.2020.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.07.012</ArticleId><ArticleId IdType="pmc">PMC7366990</ArticleId><ArticleId IdType="pubmed">32730807</ArticleId></ArticleIdList></Reference><Reference><Citation>Casalino L, et al. Beyond shielding: the roles of glycans in the SARS-CoV-2 spike protein. ACS Cent. Sci. 2020;6:1722&#x2013;1734. doi: 10.1021/acscentsci.0c01056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acscentsci.0c01056</ArticleId><ArticleId IdType="pmc">PMC7523240</ArticleId><ArticleId IdType="pubmed">33140034</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang HC, et al. Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro. EBioMedicine. 2021;74:103712. doi: 10.1016/j.ebiom.2021.103712.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103712</ArticleId><ArticleId IdType="pmc">PMC8613501</ArticleId><ArticleId IdType="pubmed">34839261</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M, Kleine-Weber H, Pohlmann S. A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells. Mol. Cell. 2020;78:779&#x2013;784.e775. doi: 10.1016/j.molcel.2020.04.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2020.04.022</ArticleId><ArticleId IdType="pmc">PMC7194065</ArticleId><ArticleId IdType="pubmed">32362314</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng YW, et al. Furin inhibitors block SARS-CoV-2 spike protein cleavage to suppress virus production and cytopathic effects. Cell Rep. 2020;33:108254. doi: 10.1016/j.celrep.2020.108254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108254</ArticleId><ArticleId IdType="pmc">PMC7510585</ArticleId><ArticleId IdType="pubmed">33007239</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Q, et al. Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration. Elife. 2020;9:e61552. doi: 10.7554/eLife.61552.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.61552</ArticleId><ArticleId IdType="pmc">PMC7685702</ArticleId><ArticleId IdType="pubmed">33103998</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, et al. Furin cleavage of the SARS-CoV-2 spike is modulated by O-glycosylation. Proc. Natl Acad. Sci. USA. 2021;118:e2109905118. doi: 10.1073/pnas.2109905118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2109905118</ArticleId><ArticleId IdType="pmc">PMC8617502</ArticleId><ArticleId IdType="pubmed">34732583</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaker SK, Ch&#x2019;ng J, Christofk HR. Viral hijacking of cellular metabolism. BMC Biol. 2019;17:59. doi: 10.1186/s12915-019-0678-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12915-019-0678-9</ArticleId><ArticleId IdType="pmc">PMC6637495</ArticleId><ArticleId IdType="pubmed">31319842</ArticleId></ArticleIdList></Reference><Reference><Citation>Twu WI, et al. Contribution of autophagy machinery factors to HCV and SARS-CoV-2 replication organelle formation. Cell Rep. 2021;37:110049. doi: 10.1016/j.celrep.2021.110049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.110049</ArticleId><ArticleId IdType="pmc">PMC8577994</ArticleId><ArticleId IdType="pubmed">34788596</ArticleId></ArticleIdList></Reference><Reference><Citation>Koepke L, Hirschenberger M, Hayn M, Kirchhoff F, Sparrer KM. Manipulation of autophagy by SARS-CoV-2 proteins. Autophagy. 2021;17:2659&#x2013;2661. doi: 10.1080/15548627.2021.1953847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2021.1953847</ArticleId><ArticleId IdType="pmc">PMC8496524</ArticleId><ArticleId IdType="pubmed">34281462</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao G, et al. ORF3a of the COVID-19 virus SARS-CoV-2 blocks HOPS complex-mediated assembly of the SNARE complex required for autolysosome formation. Dev. Cell. 2021;56:427&#x2013;442.e425. doi: 10.1016/j.devcel.2020.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.devcel.2020.12.010</ArticleId><ArticleId IdType="pmc">PMC7832235</ArticleId><ArticleId IdType="pubmed">33422265</ArticleId></ArticleIdList></Reference><Reference><Citation>Gassen NC, et al. SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS-Coronavirus infection. Nat. Commun. 2019;10:5770. doi: 10.1038/s41467-019-13659-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-13659-4</ArticleId><ArticleId IdType="pmc">PMC6920372</ArticleId><ArticleId IdType="pubmed">31852899</ArticleId></ArticleIdList></Reference><Reference><Citation>Gassen NC, et al. SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals. Nat. Commun. 2021;12:3818. doi: 10.1038/s41467-021-24007-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24007-w</ArticleId><ArticleId IdType="pmc">PMC8217552</ArticleId><ArticleId IdType="pubmed">34155207</ArticleId></ArticleIdList></Reference><Reference><Citation>Delorme-Axford E, Klionsky DJ. Highlights in the fight against COVID-19: does autophagy play a role in SARS-CoV-2 infection? Autophagy. 2020;16:2123&#x2013;2127. doi: 10.1080/15548627.2020.1844940.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2020.1844940</ArticleId><ArticleId IdType="pmc">PMC7651184</ArticleId><ArticleId IdType="pubmed">33153403</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller K, et al. Coronavirus interactions with the cellular autophagy machinery. Autophagy. 2020;16:2131&#x2013;2139. doi: 10.1080/15548627.2020.1817280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2020.1817280</ArticleId><ArticleId IdType="pmc">PMC7755319</ArticleId><ArticleId IdType="pubmed">32964796</ArticleId></ArticleIdList></Reference><Reference><Citation>Malone B, Urakova N, Snijder EJ, Campbell EA. Structures and functions of coronavirus replication-transcription complexes and their relevance for SARS-CoV-2 drug design. Nat. Rev. Mol. Cell. Biol. 2022;23:21&#x2013;39. doi: 10.1038/s41580-021-00432-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00432-z</ArticleId><ArticleId IdType="pmc">PMC8613731</ArticleId><ArticleId IdType="pubmed">34824452</ArticleId></ArticleIdList></Reference><Reference><Citation>Pombo JP, Sanyal S. Perturbation of intracellular cholesterol and fatty acid homeostasis during flavivirus infections. Front. Immunol. 2018;9:1276. doi: 10.3389/fimmu.2018.01276.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01276</ArticleId><ArticleId IdType="pmc">PMC5994796</ArticleId><ArticleId IdType="pubmed">29915602</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan B, et al. Characterization of the lipidomic profile of human coronavirus-infected cells: implications for lipid metabolism remodeling upon coronavirus replication. Viruses. 2019;11:73. doi: 10.3390/v11010073.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11010073</ArticleId><ArticleId IdType="pmc">PMC6357182</ArticleId><ArticleId IdType="pubmed">30654597</ArticleId></ArticleIdList></Reference><Reference><Citation>Heaton NS, Randall G. Multifaceted roles for lipids in viral infection. Trends Microbiol. 2011;19:368&#x2013;375. doi: 10.1016/j.tim.2011.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2011.03.007</ArticleId><ArticleId IdType="pmc">PMC3130080</ArticleId><ArticleId IdType="pubmed">21530270</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriel-Carretero M. The hypothetical role of phosphatidic acid in subverting ER membranes during SARS-CoV infection. Traffic. 2020;21:545&#x2013;551. doi: 10.1111/tra.12738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tra.12738</ArticleId><ArticleId IdType="pmc">PMC7276787</ArticleId><ArticleId IdType="pubmed">32424954</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabata K, et al. Convergent use of phosphatidic acid for hepatitis C virus and SARS-CoV-2 replication organelle formation. Nat. Commun. 2021;12:7276. doi: 10.1038/s41467-021-27511-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27511-1</ArticleId><ArticleId IdType="pmc">PMC8671429</ArticleId><ArticleId IdType="pubmed">34907161</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan B, et al. Phosphatidic acid phosphatase 1 impairs SARS-CoV-2 replication by affecting the glycerophospholipid metabolism pathway. Int. J. Biol. Sci. 2022;18:4744&#x2013;4755. doi: 10.7150/ijbs.73057.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.73057</ArticleId><ArticleId IdType="pmc">PMC9305268</ArticleId><ArticleId IdType="pubmed">35874954</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu K, Nagy PD. RNA virus replication depends on enrichment of phosphatidylethanolamine at replication sites in subcellular membranes. Proc. Natl Acad. Sci. USA. 2015;112:E1782&#x2013;E1791. doi: 10.1073/pnas.1418971112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1418971112</ArticleId><ArticleId IdType="pmc">PMC4394249</ArticleId><ArticleId IdType="pubmed">25810252</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu K, Nagy PD. Enrichment of phosphatidylethanolamine in viral replication compartments via co-opting the endosomal Rab5 small GTPase by a positive-strand RNA virus. PLoS Biol. 2016;14:e2000128. doi: 10.1371/journal.pbio.2000128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.2000128</ArticleId><ArticleId IdType="pmc">PMC5070881</ArticleId><ArticleId IdType="pubmed">27760128</ArticleId></ArticleIdList></Reference><Reference><Citation>Belov GA. Less grease, please. phosphatidylethanolamine is the only lipid required for replication of a (+)RNA virus. Viruses. 2015;7:3500&#x2013;3505. doi: 10.3390/v7072784.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v7072784</ArticleId><ArticleId IdType="pmc">PMC4517113</ArticleId><ArticleId IdType="pubmed">26131959</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Q, Lei H, Ding L, Wang Y. Stimulated phospholipid synthesis is key for hepatitis B virus replications. Sci. Rep. 2019;9:12989. doi: 10.1038/s41598-019-49367-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-49367-8</ArticleId><ArticleId IdType="pmc">PMC6736851</ArticleId><ArticleId IdType="pubmed">31506451</ArticleId></ArticleIdList></Reference><Reference><Citation>He G, et al. An engineered mutant of a host phospholipid synthesis gene inhibits viral replication without compromising host fitness. J. Biol. Chem. 2019;294:13973&#x2013;13982. doi: 10.1074/jbc.RA118.007051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.007051</ArticleId><ArticleId IdType="pmc">PMC6755795</ArticleId><ArticleId IdType="pubmed">31362985</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams CG, et al. Inhibitors of VPS34 and fatty-acid metabolism suppress SARS-CoV-2 replication. Cell Rep. 2021;36:109479. doi: 10.1016/j.celrep.2021.109479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109479</ArticleId><ArticleId IdType="pmc">PMC8289695</ArticleId><ArticleId IdType="pubmed">34320401</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu J, et al. Pharmacological inhibition of fatty acid synthesis blocks SARS-CoV-2 replication. Nat. Metab. 2021;3:1466&#x2013;1475. doi: 10.1038/s42255-021-00479-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-021-00479-4</ArticleId><ArticleId IdType="pmc">PMC8475461</ArticleId><ArticleId IdType="pubmed">34580494</ArticleId></ArticleIdList></Reference><Reference><Citation>Heaton NS, et al. Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis. Proc. Natl Acad. Sci. USA. 2010;107:17345&#x2013;17350. doi: 10.1073/pnas.1010811107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1010811107</ArticleId><ArticleId IdType="pmc">PMC2951450</ArticleId><ArticleId IdType="pubmed">20855599</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Acebes MA, Jimenez de Oya N, Saiz JC. Lipid metabolism as a source of druggable targets for antiviral discovery against Zika and other flaviviruses. Pharmaceuticals. 2019;12:97. doi: 10.3390/ph12020097.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph12020097</ArticleId><ArticleId IdType="pmc">PMC6631711</ArticleId><ArticleId IdType="pubmed">31234348</ArticleId></ArticleIdList></Reference><Reference><Citation>Crawford SE, Desselberger U. Lipid droplets form complexes with viroplasms and are crucial for rotavirus replication. Curr. Opin. Virol. 2016;19:11&#x2013;15. doi: 10.1016/j.coviro.2016.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2016.05.008</ArticleId><ArticleId IdType="pmc">PMC5125616</ArticleId><ArticleId IdType="pubmed">27341619</ArticleId></ArticleIdList></Reference><Reference><Citation>Saka HA, Valdivia R. Emerging roles for lipid droplets in immunity and host-pathogen interactions. Annu. Rev. Cell. Dev. Biol. 2012;28:411&#x2013;437. doi: 10.1146/annurev-cellbio-092910-153958.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-cellbio-092910-153958</ArticleId><ArticleId IdType="pubmed">22578141</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Lan Y, Sanyal S. Modulation of lipid droplet metabolism-A potential target for therapeutic intervention in Flaviviridae infections. Front. Microbiol. 2017;8:2286. doi: 10.3389/fmicb.2017.02286.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2017.02286</ArticleId><ArticleId IdType="pmc">PMC5712332</ArticleId><ArticleId IdType="pubmed">29234310</ArticleId></ArticleIdList></Reference><Reference><Citation>Cermelli S, Guo Y, Gross SP, Welte MA. The lipid-droplet proteome reveals that droplets are a protein-storage depot. Curr. Biol. 2006;16:1783&#x2013;1795. doi: 10.1016/j.cub.2006.07.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2006.07.062</ArticleId><ArticleId IdType="pubmed">16979555</ArticleId></ArticleIdList></Reference><Reference><Citation>Farese RV, Jr., Walther TC. Lipid droplets finally get a little R-E-S-P-E-C-T. Cell. 2009;139:855&#x2013;860. doi: 10.1016/j.cell.2009.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2009.11.005</ArticleId><ArticleId IdType="pmc">PMC3097139</ArticleId><ArticleId IdType="pubmed">19945371</ArticleId></ArticleIdList></Reference><Reference><Citation>Pol A, Gross SP, Parton RG. Review: biogenesis of the multifunctional lipid droplet: lipids, proteins, and sites. J. Cell Biol. 2014;204:635&#x2013;646. doi: 10.1083/jcb.201311051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201311051</ArticleId><ArticleId IdType="pmc">PMC3941045</ArticleId><ArticleId IdType="pubmed">24590170</ArticleId></ArticleIdList></Reference><Reference><Citation>Olzmann JA, Carvalho P. Dynamics and functions of lipid droplets. Nat. Rev. Mol. Cell. Biol. 2019;20:137&#x2013;155. doi: 10.1038/s41580-018-0085-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-018-0085-z</ArticleId><ArticleId IdType="pmc">PMC6746329</ArticleId><ArticleId IdType="pubmed">30523332</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagliari F, et al. ssRNA virus and host lipid rearrangements: is there a role for lipid droplets in SARS-CoV-2 infection? Front. Mol. Biosci. 2020;7:578964. doi: 10.3389/fmolb.2020.578964.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2020.578964</ArticleId><ArticleId IdType="pmc">PMC7579428</ArticleId><ArticleId IdType="pubmed">33134318</ArticleId></ArticleIdList></Reference><Reference><Citation>Dias SSG, et al. Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators. PLoS Pathog. 2020;16:e1009127. doi: 10.1371/journal.ppat.1009127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009127</ArticleId><ArticleId IdType="pmc">PMC7773323</ArticleId><ArticleId IdType="pubmed">33326472</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan S, et al. SARS-CoV-2 exploits host DGAT and ADRP for efficient replication. Cell Discov. 2021;7:100. doi: 10.1038/s41421-021-00338-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-021-00338-2</ArticleId><ArticleId IdType="pmc">PMC8548329</ArticleId><ArticleId IdType="pubmed">34702802</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonnesu R, et al. Palmitoylethanolamide (PEA) inhibits SARS-CoV-2 entry by interacting with S protein and ACE-2 receptor. Viruses. 2022;14:1080. doi: 10.3390/v14051080.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14051080</ArticleId><ArticleId IdType="pmc">PMC9146540</ArticleId><ArticleId IdType="pubmed">35632821</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricciardi S, et al. The role of NSP6 in the biogenesis of the SARS-CoV-2 replication organelle. Nature. 2022;606:761&#x2013;768. doi: 10.1038/s41586-022-04835-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04835-6</ArticleId><ArticleId IdType="pmc">PMC7612910</ArticleId><ArticleId IdType="pubmed">35551511</ArticleId></ArticleIdList></Reference><Reference><Citation>Moretti F, et al. TMEM41B is a novel regulator of autophagy and lipid mobilization. EMBO Rep. 2018;19:e45889. doi: 10.15252/embr.201845889.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201845889</ArticleId><ArticleId IdType="pmc">PMC6123663</ArticleId><ArticleId IdType="pubmed">30126924</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YE, et al. TMEM41B and VMP1 are scramblases and regulate the distribution of cholesterol and phosphatidylserine. J. Cell Biol. 2021;220:e202103105. doi: 10.1083/jcb.202103105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.202103105</ArticleId><ArticleId IdType="pmc">PMC8077175</ArticleId><ArticleId IdType="pubmed">33929485</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L, et al. Genome-scale CRISPR screen identifies TMEM41B as a multi-function host factor required for coronavirus replication. PLoS Pathog. 2021;17:e1010113. doi: 10.1371/journal.ppat.1010113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010113</ArticleId><ArticleId IdType="pmc">PMC8675922</ArticleId><ArticleId IdType="pubmed">34871328</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji M, et al. VMP1 and TMEM41B are essential for DMV formation during beta-coronavirus infection. J. Cell Biol. 2022;221:e202112081. doi: 10.1083/jcb.202112081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.202112081</ArticleId><ArticleId IdType="pmc">PMC9097365</ArticleId><ArticleId IdType="pubmed">35536318</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoemaker CJ, et al. CRISPR screening using an expanded toolkit of autophagy reporters identifies TMEM41B as a novel autophagy factor. PLoS Biol. 2019;17:e2007044. doi: 10.1371/journal.pbio.2007044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.2007044</ArticleId><ArticleId IdType="pmc">PMC6459555</ArticleId><ArticleId IdType="pubmed">30933966</ArticleId></ArticleIdList></Reference><Reference><Citation>Morita K, et al. Genome-wide CRISPR screen identifies TMEM41B as a gene required for autophagosome formation. J. Cell Biol. 2018;217:3817&#x2013;3828. doi: 10.1083/jcb.201804132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201804132</ArticleId><ArticleId IdType="pmc">PMC6219718</ArticleId><ArticleId IdType="pubmed">30093494</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider WM, et al. Genome-scale identification of SARS-CoV-2 and Pan-coronavirus host factor networks. Cell. 2021;184:120&#x2013;132.e114. doi: 10.1016/j.cell.2020.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.12.006</ArticleId><ArticleId IdType="pmc">PMC7796900</ArticleId><ArticleId IdType="pubmed">33382968</ArticleId></ArticleIdList></Reference><Reference><Citation>Trimarco JD, et al. TMEM41B is a host factor required for the replication of diverse coronaviruses including SARS-CoV-2. PLoS pathog. 2021;17:e1009599. doi: 10.1371/journal.ppat.1009599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009599</ArticleId><ArticleId IdType="pmc">PMC8189496</ArticleId><ArticleId IdType="pubmed">34043740</ArticleId></ArticleIdList></Reference><Reference><Citation>Kratzel A, et al. A genome-wide CRISPR screen identifies interactors of the autophagy pathway as conserved coronavirus targets. PLoS Biol. 2021;19:e3001490. doi: 10.1371/journal.pbio.3001490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3001490</ArticleId><ArticleId IdType="pmc">PMC8741300</ArticleId><ArticleId IdType="pubmed">34962926</ArticleId></ArticleIdList></Reference><Reference><Citation>Icard P, et al. The key role of Warburg effect in SARS-CoV-2 replication and associated inflammatory response. Biochimie. 2021;180:169&#x2013;177. doi: 10.1016/j.biochi.2020.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2020.11.010</ArticleId><ArticleId IdType="pmc">PMC7659517</ArticleId><ArticleId IdType="pubmed">33189832</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy S, Demmer RT. Impaired glucose regulation, SARS-CoV-2 infections and adverse COVID-19 outcomes. Transl. Res. 2022;241:52&#x2013;69. doi: 10.1016/j.trsl.2021.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575538</ArticleId><ArticleId IdType="pubmed">34763125</ArticleId></ArticleIdList></Reference><Reference><Citation>Montefusco L, et al. Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat. Metab. 2021;3:774&#x2013;785. doi: 10.1038/s42255-021-00407-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-021-00407-6</ArticleId><ArticleId IdType="pmc">PMC9931026</ArticleId><ArticleId IdType="pubmed">34035524</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez EL, Lagunoff M. Viral activation of cellular metabolism. Virology. 2015;479:609&#x2013;618. doi: 10.1016/j.virol.2015.02.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2015.02.038</ArticleId><ArticleId IdType="pmc">PMC4424078</ArticleId><ArticleId IdType="pubmed">25812764</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S, et al. AMP-activated protein kinase restricts Zika virus replication in endothelial cells by potentiating innate antiviral responses and inhibiting glycolysis. J. Immunol. 2020;204:1810&#x2013;1824. doi: 10.4049/jimmunol.1901310.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1901310</ArticleId><ArticleId IdType="pmc">PMC7310572</ArticleId><ArticleId IdType="pubmed">32086387</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, et al. SARS-CoV-2 hijacks folate and one-carbon metabolism for viral replication. Nat. Commun. 2021;12:1676. doi: 10.1038/s41467-021-21903-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21903-z</ArticleId><ArticleId IdType="pmc">PMC7960988</ArticleId><ArticleId IdType="pubmed">33723254</ArticleId></ArticleIdList></Reference><Reference><Citation>Bojkova D, et al. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets. Nature. 2020;583:469&#x2013;472. doi: 10.1038/s41586-020-2332-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2332-7</ArticleId><ArticleId IdType="pubmed">32408336</ArticleId></ArticleIdList></Reference><Reference><Citation>Codo AC, et al. Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1alpha/glycolysis-dependent axis. Cell Metab. 2020;32:437&#x2013;446.e435. doi: 10.1016/j.cmet.2020.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.07.007</ArticleId><ArticleId IdType="pmc">PMC7367032</ArticleId><ArticleId IdType="pubmed">32697943</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan X, et al. An airway organoid-based screen identifies a role for the HIF1alpha-glycolysis axis in SARS-CoV-2 infection. Cell Rep. 2021;37:109920. doi: 10.1016/j.celrep.2021.109920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109920</ArticleId><ArticleId IdType="pmc">PMC8516798</ArticleId><ArticleId IdType="pubmed">34731648</ArticleId></ArticleIdList></Reference><Reference><Citation>Stincone A, et al. The return of metabolism: biochemistry and physiology of the pentose phosphate pathway. Biol. Rev. Camb. Philos. Soc. 2015;90:927&#x2013;963. doi: 10.1111/brv.12140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/brv.12140</ArticleId><ArticleId IdType="pmc">PMC4470864</ArticleId><ArticleId IdType="pubmed">25243985</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang P, Du W, Wu M. Regulation of the pentose phosphate pathway in cancer. Protein Cell. 2014;5:592&#x2013;602. doi: 10.1007/s13238-014-0082-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-014-0082-8</ArticleId><ArticleId IdType="pmc">PMC4112277</ArticleId><ArticleId IdType="pubmed">25015087</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos ESJC, et al. Gene signatures of autopsy lungs from obese patients with COVID-19. Clin. Nutr. Espen. 2021;44:475&#x2013;478. doi: 10.1016/j.clnesp.2021.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnesp.2021.05.004</ArticleId><ArticleId IdType="pmc">PMC8149170</ArticleId><ArticleId IdType="pubmed">34330510</ArticleId></ArticleIdList></Reference><Reference><Citation>Bojkova D, et al. Targeting the pentose phosphate pathway for SARS-CoV-2 therapy. Metabolites. 2021;11:699. doi: 10.3390/metabo11100699.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo11100699</ArticleId><ArticleId IdType="pmc">PMC8540749</ArticleId><ArticleId IdType="pubmed">34677415</ArticleId></ArticleIdList></Reference><Reference><Citation>Ducker GS, Rabinowitz JD. One-carbon metabolism in health and disease. Cell Metab. 2017;25:27&#x2013;42. doi: 10.1016/j.cmet.2016.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2016.08.009</ArticleId><ArticleId IdType="pmc">PMC5353360</ArticleId><ArticleId IdType="pubmed">27641100</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiraoka M, Kagawa Y. Genetic polymorphisms and folate status. Congenit. Anom. 2017;57:142&#x2013;149. doi: 10.1111/cga.12232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cga.12232</ArticleId><ArticleId IdType="pmc">PMC5601299</ArticleId><ArticleId IdType="pubmed">28598562</ArticleId></ArticleIdList></Reference><Reference><Citation>Decroly E, Ferron F, Lescar J, Canard B. Conventional and unconventional mechanisms for capping viral mRNA. Nat. Rev. Microbiol. 2011;10:51&#x2013;65. doi: 10.1038/nrmicro2675.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro2675</ArticleId><ArticleId IdType="pmc">PMC7097100</ArticleId><ArticleId IdType="pubmed">22138959</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Guo D. Molecular mechanisms of coronavirus RNA capping and methylation. Virol. Sin. 2016;31:3&#x2013;11. doi: 10.1007/s12250-016-3726-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-016-3726-4</ArticleId><ArticleId IdType="pmc">PMC7091378</ArticleId><ArticleId IdType="pubmed">26847650</ArticleId></ArticleIdList></Reference><Reference><Citation>Sevajol M, Subissi L, Decroly E, Canard B, Imbert I. Insights into RNA synthesis, capping, and proofreading mechanisms of SARS-coronavirus. Virus Res. 2014;194:90&#x2013;99. doi: 10.1016/j.virusres.2014.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2014.10.008</ArticleId><ArticleId IdType="pmc">PMC7114481</ArticleId><ArticleId IdType="pubmed">25451065</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandilara G, et al. The role of coronavirus RNA-processing enzymes in innate immune evasion. Life (Basel) 2021;11:571.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8235370</ArticleId><ArticleId IdType="pubmed">34204549</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan L, et al. Coupling of N7-methyltransferase and 3&#x2019;-5&#x2019; exoribonuclease with SARS-CoV-2 polymerase reveals mechanisms for capping and proofreading. Cell. 2021;184:3474&#x2013;3485 e3411. doi: 10.1016/j.cell.2021.05.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.05.033</ArticleId><ArticleId IdType="pmc">PMC8142856</ArticleId><ArticleId IdType="pubmed">34143953</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano M, Ruggiero A, Squeglia F, Maga G, Berisio R. A structural view of SARS-CoV-2 RNA replication machinery: RNA synthesis, proofreading and final capping. Cells. 2020;9:1267. doi: 10.3390/cells9051267.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9051267</ArticleId><ArticleId IdType="pmc">PMC7291026</ArticleId><ArticleId IdType="pubmed">32443810</ArticleId></ArticleIdList></Reference><Reference><Citation>Mentch SJ, Locasale JW. One-carbon metabolism and epigenetics: understanding the specificity. Ann. N. Y. Acad. Sci. 2016;1363:91&#x2013;98. doi: 10.1111/nyas.12956.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.12956</ArticleId><ArticleId IdType="pmc">PMC4801744</ArticleId><ArticleId IdType="pubmed">26647078</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergant V, et al. Attenuation of SARS-CoV-2 replication and associated inflammation by concomitant targeting of viral and host cap 2&#x2019;-O-ribose methyltransferases. EMBO J. 2022;41:e111608. doi: 10.15252/embj.2022111608.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2022111608</ArticleId><ArticleId IdType="pmc">PMC9350232</ArticleId><ArticleId IdType="pubmed">35833542</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack A, et al. SARS-CoV-2 nucleocapsid protein forms condensates with viral genomic RNA. PLoS Biol. 2021;19:e3001425. doi: 10.1371/journal.pbio.3001425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.3001425</ArticleId><ArticleId IdType="pmc">PMC8553124</ArticleId><ArticleId IdType="pubmed">34634033</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo H, et al. Severe acute respiratory syndrome coronavirus membrane protein interacts with nucleocapsid protein mostly through their carboxyl termini by electrostatic attraction. Int. J. Biochem. Cell Biol. 2006;38:589&#x2013;599. doi: 10.1016/j.biocel.2005.10.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2005.10.022</ArticleId><ArticleId IdType="pmc">PMC7108423</ArticleId><ArticleId IdType="pubmed">16343974</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman BW, et al. A structural analysis of M protein in coronavirus assembly and morphology. J. Struct. Biol. 2011;174:11&#x2013;22. doi: 10.1016/j.jsb.2010.11.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2010.11.021</ArticleId><ArticleId IdType="pmc">PMC4486061</ArticleId><ArticleId IdType="pubmed">21130884</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas S. The structure of the membrane protein of SARS-CoV-2 resembles the sugar transporter SemiSWEET. Pathog. Immun. 2020;5:342&#x2013;363. doi: 10.20411/pai.v5i1.377.</Citation><ArticleIdList><ArticleId IdType="doi">10.20411/pai.v5i1.377</ArticleId><ArticleId IdType="pmc">PMC7608487</ArticleId><ArticleId IdType="pubmed">33154981</ArticleId></ArticleIdList></Reference><Reference><Citation>Mortola E, Roy P. Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system. FEBS Lett. 2004;576:174&#x2013;178. doi: 10.1016/j.febslet.2004.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2004.09.009</ArticleId><ArticleId IdType="pmc">PMC7126153</ArticleId><ArticleId IdType="pubmed">15474033</ArticleId></ArticleIdList></Reference><Reference><Citation>Corse E, Machamer CE. The cytoplasmic tails of infectious bronchitis virus E and M proteins mediate their interaction. Virology. 2003;312:25&#x2013;34. doi: 10.1016/S0042-6822(03)00175-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0042-6822(03)00175-2</ArticleId><ArticleId IdType="pmc">PMC7127533</ArticleId><ArticleId IdType="pubmed">12890618</ArticleId></ArticleIdList></Reference><Reference><Citation>Baudoux P, et al. Coronavirus pseudoparticles formed with recombinant M and E proteins induce alpha interferon synthesis by leukocytes. J. Virol. 1998;72:8636&#x2013;8643. doi: 10.1128/JVI.72.11.8636-8643.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.72.11.8636-8643.1998</ArticleId><ArticleId IdType="pmc">PMC110275</ArticleId><ArticleId IdType="pubmed">9765403</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan Z, et al. The E3 ubiquitin ligase RNF5 facilitates SARS-CoV-2 membrane protein-mediated virion release. MBIO. 2022;13:e03168&#x2013;21. doi: 10.1128/mbio.03168-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.03168-21</ArticleId><ArticleId IdType="pmc">PMC8805027</ArticleId><ArticleId IdType="pubmed">35100873</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera-Garcia D, et al. The envelope protein of SARS-CoV-2 increases intra-Golgi pH and forms a cation channel that is regulated by pH. J. Physiol. 2021;599:2851&#x2013;2861. doi: 10.1113/JP281037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP281037</ArticleId><ArticleId IdType="pmc">PMC8251088</ArticleId><ArticleId IdType="pubmed">33709461</ArticleId></ArticleIdList></Reference><Reference><Citation>Boson B, et al. The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, allowing assembly of virus-like particles. J. Biol. Chem. 2021;296:100111. doi: 10.1074/jbc.RA120.016175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA120.016175</ArticleId><ArticleId IdType="pmc">PMC7833635</ArticleId><ArticleId IdType="pubmed">33229438</ArticleId></ArticleIdList></Reference><Reference><Citation>Eymieux S, et al. Secretory vesicles are the principal means of SARS-CoV-2 Egress. Cells. 2021;10:2047. doi: 10.3390/cells10082047.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10082047</ArticleId><ArticleId IdType="pmc">PMC8393858</ArticleId><ArticleId IdType="pubmed">34440816</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje-Galvan, V. &amp; Voth, G. A. Molecular interactions of the M and E integral membrane proteins of SARS-CoV-2. bioRxiv (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8712422</ArticleId><ArticleId IdType="pubmed">34543372</ArticleId></ArticleIdList></Reference><Reference><Citation>Raamsman MJB, et al. Characterization of the coronavirus mouse hepatitis virus strain A59 small membrane protein E. J. Viol. 2000;74:2333&#x2013;2342.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC111715</ArticleId><ArticleId IdType="pubmed">10666264</ArticleId></ArticleIdList></Reference><Reference><Citation>Veit M. Palmitoylation of virus proteins. Biol. Cell. 2012;104:493&#x2013;515. doi: 10.1111/boc.201200006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/boc.201200006</ArticleId><ArticleId IdType="pmc">PMC7161805</ArticleId><ArticleId IdType="pubmed">22548323</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Yang C, Tong S, Weidmann A, Compans RW. Palmitoylation of the murine leukemia virus envelope protein is critical for lipid raft association and surface expression. J. Virol. 2002;76:11845&#x2013;11852. doi: 10.1128/JVI.76.23.11845-11852.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.76.23.11845-11852.2002</ArticleId><ArticleId IdType="pmc">PMC136891</ArticleId><ArticleId IdType="pubmed">12414927</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscarino JA, Logan HL, Lacny JJ, Gallagher TM. Envelope protein palmitoylations are crucial for murine coronavirus assembly. J. Virol. 2008;82:2989&#x2013;2999. doi: 10.1128/JVI.01906-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01906-07</ArticleId><ArticleId IdType="pmc">PMC2258982</ArticleId><ArticleId IdType="pubmed">18184706</ArticleId></ArticleIdList></Reference><Reference><Citation>Resh MD. Fatty acylation of proteins: the long and the short of it. Prog. Lipid Res. 2016;63:120&#x2013;131. doi: 10.1016/j.plipres.2016.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.plipres.2016.05.002</ArticleId><ArticleId IdType="pmc">PMC4975971</ArticleId><ArticleId IdType="pubmed">27233110</ArticleId></ArticleIdList></Reference><Reference><Citation>Rana MS, Lee CJ, Banerjee A. The molecular mechanism of DHHC protein acyltransferases. Biochem. Soc. Trans. 2019;47:157&#x2013;167. doi: 10.1042/BST20180429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST20180429</ArticleId><ArticleId IdType="pubmed">30559274</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez LA, Riffle AJ, Pike SL, Gardner D, Hogue BG. Importance of conserved cysteine residues in the coronavirus envelope protein. J. Virol. 2008;82:3000&#x2013;3010. doi: 10.1128/JVI.01914-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01914-07</ArticleId><ArticleId IdType="pmc">PMC2258990</ArticleId><ArticleId IdType="pubmed">18184703</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y, Yuan Q, Torres J, Tam JP, Liu DX. Biochemical and functional characterization of the membrane association and membrane permeabilizing activity of the severe acute respiratory syndrome coronavirus envelope protein. Virology. 2006;349:264&#x2013;275. doi: 10.1016/j.virol.2006.01.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2006.01.028</ArticleId><ArticleId IdType="pmc">PMC7111751</ArticleId><ArticleId IdType="pubmed">16507314</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S, et al. Computational study on the function of palmitoylation on the envelope protein in SARS-CoV-2. J. Chem. Theory Comput. 2021;17:6483&#x2013;6490. doi: 10.1021/acs.jctc.1c00359.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jctc.1c00359</ArticleId><ArticleId IdType="pmc">PMC8457325</ArticleId><ArticleId IdType="pubmed">34516136</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuzmin A, Orekhov P, Astashkin R, Gordeliy V, Gushchin I. Structure and dynamics of the SARS-CoV-2 envelope protein monomer. Proteins. 2022;90:1102&#x2013;1114. doi: 10.1002/prot.26317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.26317</ArticleId><ArticleId IdType="pubmed">35119706</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Y, et al. Analysis of 2019 novel coronavirus infection and clinical characteristics of outpatients: an epidemiological study from a fever clinic in Wuhan, China. J. Med. Virol. 2020;92:2758&#x2013;2767. doi: 10.1002/jmv.26175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26175</ArticleId><ArticleId IdType="pmc">PMC7323042</ArticleId><ArticleId IdType="pubmed">32544281</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo MW, Kemper C, Woodruff TM. COVID-19: complement, coagulation, and collateral damage. J. Immunol. 2020;205:1488&#x2013;1495. doi: 10.4049/jimmunol.2000644.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2000644</ArticleId><ArticleId IdType="pmc">PMC7484432</ArticleId><ArticleId IdType="pubmed">32699160</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin C, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin. Infect. Dis. 2020;71:762&#x2013;768. doi: 10.1093/cid/ciaa248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa248</ArticleId><ArticleId IdType="pmc">PMC7108125</ArticleId><ArticleId IdType="pubmed">32161940</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco-Melo D, et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 2020;181:1036&#x2013;1045.e1039. doi: 10.1016/j.cell.2020.04.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.026</ArticleId><ArticleId IdType="pmc">PMC7227586</ArticleId><ArticleId IdType="pubmed">32416070</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Wu M, Li Y, Yuen HH, He ML. The effects of SARS-CoV-2 infection on modulating innate immunity and strategies of combating inflammatory response for COVID-19 therapy. J. Biomed. Sci. 2022;29:27. doi: 10.1186/s12929-022-00811-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-022-00811-4</ArticleId><ArticleId IdType="pmc">PMC9063252</ArticleId><ArticleId IdType="pubmed">35505345</ArticleId></ArticleIdList></Reference><Reference><Citation>Kouwaki T, Nishimura T, Wang G, Oshiumi H. RIG-I-like receptor-mediated recognition of viral genomic RNA of severe acute respiratory syndrome coronavirus-2 and viral escape from the host innate immune responses. Front. Immunol. 2021;12:700926. doi: 10.3389/fimmu.2021.700926.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.700926</ArticleId><ArticleId IdType="pmc">PMC8267574</ArticleId><ArticleId IdType="pubmed">34249006</ArticleId></ArticleIdList></Reference><Reference><Citation>Aboudounya MM, Heads RJ. COVID-19 and toll-like receptor 4 (TLR4): SARS-CoV-2 may bind and activate TLR4 to increase ACE2 expression, facilitating entry and causing hyperinflammation. Mediat. Inflamm. 2021;2021:8874339. doi: 10.1155/2021/8874339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/8874339</ArticleId><ArticleId IdType="pmc">PMC7811571</ArticleId><ArticleId IdType="pubmed">33505220</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues TS, et al. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. J. Exp. Med. 2021;218:e20201707. doi: 10.1084/jem.20201707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20201707</ArticleId><ArticleId IdType="pmc">PMC7684031</ArticleId><ArticleId IdType="pubmed">33231615</ArticleId></ArticleIdList></Reference><Reference><Citation>Toldo S, et al. Inflammasome formation in the lungs of patients with fatal COVID-19. Inflamm. Res. 2021;70:7&#x2013;10. doi: 10.1007/s00011-020-01413-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-020-01413-2</ArticleId><ArticleId IdType="pmc">PMC7572246</ArticleId><ArticleId IdType="pubmed">33079210</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu B, et al. ORAI1 limits SARS-CoV-2 infection by regulating tonic type I IFN signaling. J. Immunol. 2022;208:74&#x2013;84. doi: 10.4049/jimmunol.2100742.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2100742</ArticleId><ArticleId IdType="pmc">PMC8702473</ArticleId><ArticleId IdType="pubmed">34819389</ArticleId></ArticleIdList></Reference><Reference><Citation>Quarleri J, Delpino MV. Type I and III IFN-mediated antiviral actions counteracted by SARS-CoV-2 proteins and host inherited factors. Cytokine Growth Factor Rev. 2021;58:55&#x2013;65. doi: 10.1016/j.cytogfr.2021.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2021.01.003</ArticleId><ArticleId IdType="pmc">PMC7871890</ArticleId><ArticleId IdType="pubmed">33608189</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers MM, Haagmans BL. SARS-CoV-2 pathogenesis. Nat. Rev. Microbiol. 2022;20:270&#x2013;284. doi: 10.1038/s41579-022-00713-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00713-0</ArticleId><ArticleId IdType="pubmed">35354968</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng BJ, et al. Potent inhibition of SARS-associated coronavirus (SCOV) infection and replication by type I interferons (IFN-alpha beta) but not by type II interferon (IFN-gamma) J. Interf. Cytok. Res. 2004;24:388&#x2013;390. doi: 10.1089/1079990041535610.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/1079990041535610</ArticleId><ArticleId IdType="pubmed">15296649</ArticleId></ArticleIdList></Reference><Reference><Citation>Yongzhi X. COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue. Emerg. Microbes Infect. 2021;10:266&#x2013;276. doi: 10.1080/22221751.2021.1884503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2021.1884503</ArticleId><ArticleId IdType="pmc">PMC7894425</ArticleId><ArticleId IdType="pubmed">33522893</ArticleId></ArticleIdList></Reference><Reference><Citation>Olbei M, et al. SARS-CoV-2 causes a different cytokine response compared to other cytokine storm-causing respiratory viruses in severely Ill patients. Front. Immunol. 2021;12:629193. doi: 10.3389/fimmu.2021.629193.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.629193</ArticleId><ArticleId IdType="pmc">PMC7956943</ArticleId><ArticleId IdType="pubmed">33732251</ArticleId></ArticleIdList></Reference><Reference><Citation>Karki R, et al. Synergism of TNF-alpha and IFN-gamma triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell. 2021;184:149&#x2013;168.e117. doi: 10.1016/j.cell.2020.11.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.11.025</ArticleId><ArticleId IdType="pmc">PMC7674074</ArticleId><ArticleId IdType="pubmed">33278357</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou YG, et al. Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients. Natl Sci. Rev. 2020;7:998&#x2013;1002. doi: 10.1093/nsr/nwaa041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nsr/nwaa041</ArticleId><ArticleId IdType="pmc">PMC7108005</ArticleId><ArticleId IdType="pubmed">34676125</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Invest. 2020;130:2620&#x2013;2629. doi: 10.1172/JCI137244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI137244</ArticleId><ArticleId IdType="pmc">PMC7190990</ArticleId><ArticleId IdType="pubmed">32217835</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat. Rev. Immunol. 2020;20:355&#x2013;362. doi: 10.1038/s41577-020-0331-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0331-4</ArticleId><ArticleId IdType="pmc">PMC7201395</ArticleId><ArticleId IdType="pubmed">32376901</ArticleId></ArticleIdList></Reference><Reference><Citation>Dolhnikoff M, et al. Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19. J. Thromb. Haemost. 2020;18:1517&#x2013;1519. doi: 10.1111/jth.14844.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14844</ArticleId><ArticleId IdType="pmc">PMC7262093</ArticleId><ArticleId IdType="pubmed">32294295</ArticleId></ArticleIdList></Reference><Reference><Citation>Menter T, et al. Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology. 2020;77:198&#x2013;209. doi: 10.1111/his.14134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/his.14134</ArticleId><ArticleId IdType="pmc">PMC7496150</ArticleId><ArticleId IdType="pubmed">32364264</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N. Engl. J. Med. 2020;383:120&#x2013;128. doi: 10.1056/NEJMoa2015432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu SX, et al. Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation. Nat. Rev. Cardiol. 2021;18:194&#x2013;209. doi: 10.1038/s41569-020-00469-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-00469-1</ArticleId><ArticleId IdType="pmc">PMC7675396</ArticleId><ArticleId IdType="pubmed">33214651</ArticleId></ArticleIdList></Reference><Reference><Citation>Villar J, et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir. Med. 2020;8:267&#x2013;276. doi: 10.1016/S2213-2600(19)30417-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(19)30417-5</ArticleId><ArticleId IdType="pubmed">32043986</ArticleId></ArticleIdList></Reference><Reference><Citation>Group RC, et al. Dexamethasone in hospitalized patients with Covid-19. N. Engl. J. Med. 2021;384:693&#x2013;704. doi: 10.1056/NEJMoa2021436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021436</ArticleId><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrmann S, et al. Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial. Lancet Respir. Med. 2021;9:1387&#x2013;1395. doi: 10.1016/S2213-2600(21)00356-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00356-8</ArticleId><ArticleId IdType="pmc">PMC8378833</ArticleId><ArticleId IdType="pubmed">34425070</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaid Y, et al. Chemokines and eicosanoids fuel the hyperinflammation within the lungs of patients with severe COVID-19. J. Allergy Clin. Immunol. 2021;148:368&#x2013;380.e363. doi: 10.1016/j.jaci.2021.05.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2021.05.032</ArticleId><ArticleId IdType="pmc">PMC8180473</ArticleId><ArticleId IdType="pubmed">34111453</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuypers FA, et al. Secretory phospholipase A2 in SARS-CoV-2 infection and multisystem inflammatory syndrome in children (MIS-C) Exp. Biol. Med. 2021;246:2543&#x2013;2552. doi: 10.1177/15353702211028560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/15353702211028560</ArticleId><ArticleId IdType="pmc">PMC8649422</ArticleId><ArticleId IdType="pubmed">34255566</ArticleId></ArticleIdList></Reference><Reference><Citation>Kott M, et al. Acid Sphingomyelinase Serum Activity Predicts Mortality in Intensive Care Unit Patients after Systemic Inflammation: A Prospective Cohort Study. PLoS ONE. 2014;9:e112323. doi: 10.1371/journal.pone.0112323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0112323</ArticleId><ArticleId IdType="pmc">PMC4226549</ArticleId><ArticleId IdType="pubmed">25384060</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler. Thromb. Vasc. Biol. 2011;31:986&#x2013;1000. doi: 10.1161/ATVBAHA.110.207449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.110.207449</ArticleId><ArticleId IdType="pmc">PMC3081099</ArticleId><ArticleId IdType="pubmed">21508345</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, J. S. et al. Cyclooxgenase-2 is induced by SARS-CoV-2 infection but does not affect viral entry or replication. Preprint at bioRxiv10.1101/2020.09.24.312769 (2020).</Citation></Reference><Reference><Citation>Tan L, et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct. Target. Ther. 2020;5:33. doi: 10.1038/s41392-020-0148-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-0148-4</ArticleId><ArticleId IdType="pmc">PMC7100419</ArticleId><ArticleId IdType="pubmed">32296069</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricke-Hoch M, et al. Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease. PLoS ONE. 2021;16:e0255335. doi: 10.1371/journal.pone.0255335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0255335</ArticleId><ArticleId IdType="pmc">PMC8336874</ArticleId><ArticleId IdType="pubmed">34347801</ArticleId></ArticleIdList></Reference><Reference><Citation>Aliabadi F, Ajami M, Pazoki-Toroudi H. Why does COVID-19 pathology have several clinical forms? BioEssays. 2020;42:e2000198. doi: 10.1002/bies.202000198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.202000198</ArticleId><ArticleId IdType="pubmed">33174637</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Chander Chiang K. Prostaglandin D2 as a mediator of lymphopenia and a therapeutic target in COVID-19 disease. Med. Hypotheses. 2020;143:110122. doi: 10.1016/j.mehy.2020.110122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110122</ArticleId><ArticleId IdType="pmc">PMC7373045</ArticleId><ArticleId IdType="pubmed">32759007</ArticleId></ArticleIdList></Reference><Reference><Citation>Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 2008;8:349&#x2013;361. doi: 10.1038/nri2294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2294</ArticleId><ArticleId IdType="pmc">PMC2744593</ArticleId><ArticleId IdType="pubmed">18437155</ArticleId></ArticleIdList></Reference><Reference><Citation>Manne BK, et al. Platelet gene expression and function in patients with COVID-19. Blood. 2020;136:1317&#x2013;1329. doi: 10.1182/blood.2020007214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020007214</ArticleId><ArticleId IdType="pmc">PMC7483430</ArticleId><ArticleId IdType="pubmed">32573711</ArticleId></ArticleIdList></Reference><Reference><Citation>Manne BK, et al. PDK1 governs thromboxane generation and thrombosis in platelets by regulating activation of Raf1 in the MAPK pathway. J. Thromb. Haemost. 2018;16:1211&#x2013;1225. doi: 10.1111/jth.14005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14005</ArticleId><ArticleId IdType="pmc">PMC5984143</ArticleId><ArticleId IdType="pubmed">29575487</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelfand EW. Importance of the leukotriene B4-BLT1 and LTB4-BLT2 pathways in asthma. Semin. Immunol. 2017;33:44&#x2013;51. doi: 10.1016/j.smim.2017.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2017.08.005</ArticleId><ArticleId IdType="pmc">PMC5679233</ArticleId><ArticleId IdType="pubmed">29042028</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto K, et al. Cysteinyl leukotrienes induce monocyte chemoattractant protein-1 in human monocyte/macrophages via mitogen-activated protein kinase and nuclear factor-kappaB pathways. Int. Arch. Allergy Immunol. 2009;149:275&#x2013;282. doi: 10.1159/000199724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000199724</ArticleId><ArticleId IdType="pubmed">19218821</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodarzi K, Goodarzi M, Tager AM, Luster AD, von Andrian UH. Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues. Nat. Immunol. 2003;4:965&#x2013;973. doi: 10.1038/ni972.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni972</ArticleId><ArticleId IdType="pubmed">12949533</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gennaro A, Haeggstrom JZ. The leukotrienes: immune-modulating lipid mediators of disease. Adv. Immunol. 2012;116:51&#x2013;92. doi: 10.1016/B978-0-12-394300-2.00002-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-394300-2.00002-8</ArticleId><ArticleId IdType="pubmed">23063073</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong M, Zhang H, Cao X, Mao X, Lu Z. Higher level of neutrophil-to-lymphocyte is associated with severe COVID-19. Epidemiol. Infect. 2020;148:e139. doi: 10.1017/S0950268820001557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268820001557</ArticleId><ArticleId IdType="pmc">PMC7360950</ArticleId><ArticleId IdType="pubmed">32641174</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilk AJ, et al. A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nat. Med. 2020;26:1070&#x2013;1076. doi: 10.1038/s41591-020-0944-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0944-y</ArticleId><ArticleId IdType="pmc">PMC7382903</ArticleId><ArticleId IdType="pubmed">32514174</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao M, et al. Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat. Med. 2020;26:842&#x2013;844. doi: 10.1038/s41591-020-0901-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0901-9</ArticleId><ArticleId IdType="pubmed">32398875</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, et al. Leukotriene B4 strongly increases monocyte chemoattractant protein-1 in human monocytes. Arterioscler. Thromb. Vasc. Biol. 2004;24:1783&#x2013;1788. doi: 10.1161/01.ATV.0000140063.06341.09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.ATV.0000140063.06341.09</ArticleId><ArticleId IdType="pubmed">15271789</ArticleId></ArticleIdList></Reference><Reference><Citation>Brach MA, et al. Leukotriene B4 transcriptionally activates interleukin-6 expression involving NK-xB and NF-IL6. Eur. J. Immunol. 1992;22:2705&#x2013;2711. doi: 10.1002/eji.1830221034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.1830221034</ArticleId><ArticleId IdType="pubmed">1327803</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, et al. Cysteinyl leukotriene receptor 2 drives lung immunopathology through a platelet and high mobility box 1-dependent mechanism. Mucosal Immunol. 2019;12:679&#x2013;690. doi: 10.1038/s41385-019-0134-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-019-0134-8</ArticleId><ArticleId IdType="pmc">PMC6462243</ArticleId><ArticleId IdType="pubmed">30664709</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings HE, et al. Cutting edge: Leukotriene C4 activates mouse platelets in plasma exclusively through the type 2 cysteinyl leukotriene receptor. J. Immunol. 2013;191:5807&#x2013;5810. doi: 10.4049/jimmunol.1302187.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1302187</ArticleId><ArticleId IdType="pmc">PMC3869987</ArticleId><ArticleId IdType="pubmed">24244016</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X, et al. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2. Eur. J. Nucl. Med. Mol. Imaging. 2020;47:1275&#x2013;1280. doi: 10.1007/s00259-020-04735-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-04735-9</ArticleId><ArticleId IdType="pmc">PMC7080117</ArticleId><ArticleId IdType="pubmed">32107577</ArticleId></ArticleIdList></Reference><Reference><Citation>Archambault AS, et al. High levels of eicosanoids and docosanoids in the lungs of intubated COVID-19 patients. Faseb J. 2021;35:e21666. doi: 10.1096/fj.202100540R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202100540R</ArticleId><ArticleId IdType="pmc">PMC8206770</ArticleId><ArticleId IdType="pubmed">34033145</ArticleId></ArticleIdList></Reference><Reference><Citation>Spector AA. Arachidonic acid cytochrome P450 epoxygenase pathway. J. Lipid Res. 2009;50:S52&#x2013;S56. doi: 10.1194/jlr.R800038-JLR200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.R800038-JLR200</ArticleId><ArticleId IdType="pmc">PMC2674692</ArticleId><ArticleId IdType="pubmed">18952572</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilroy DW, et al. CYP450-derived oxylipins mediate inflammatory resolution. Proc. Natl Acad. Sci. USA. 2016;113:E3240&#x2013;E3249. doi: 10.1073/pnas.1521453113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1521453113</ArticleId><ArticleId IdType="pmc">PMC4988604</ArticleId><ArticleId IdType="pubmed">27226306</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Y, et al. Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice. FASEB J. 2011;25:703&#x2013;713. doi: 10.1096/fj.10-171488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.10-171488</ArticleId><ArticleId IdType="pmc">PMC3023387</ArticleId><ArticleId IdType="pubmed">21059750</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, et al. Soluble epoxide hydrolase inhibitor attenuates lipopolysaccharide-induced acute lung injury and improves survival in mice. Shock. 2017;47:638&#x2013;645. doi: 10.1097/SHK.0000000000000767.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0000000000000767</ArticleId><ArticleId IdType="pmc">PMC5382142</ArticleId><ArticleId IdType="pubmed">27753791</ArticleId></ArticleIdList></Reference><Reference><Citation>Arshad H, et al. Decreased plasma phospholipid concentrations and increased acid sphingomyelinase activity are accurate biomarkers for community-acquired pneumonia. J. Transl. Med. 2019;17:365. doi: 10.1186/s12967-019-2112-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-019-2112-z</ArticleId><ArticleId IdType="pmc">PMC6849224</ArticleId><ArticleId IdType="pubmed">31711507</ArticleId></ArticleIdList></Reference><Reference><Citation>Beckmann N, et al. Regulation of arthritis severity by the acid sphingomyelinase. Cell Physiol. Biochem. 2017;43:1460&#x2013;1471. doi: 10.1159/000481968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000481968</ArticleId><ArticleId IdType="pubmed">29035882</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung HY, et al. Acid sphingomyelinase promotes endothelial stress response in systemic inflammation and sepsis. Mol. Med. 2016;22:412&#x2013;423. doi: 10.2119/molmed.2016.00140.</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/molmed.2016.00140</ArticleId><ArticleId IdType="pmc">PMC5072414</ArticleId><ArticleId IdType="pubmed">27341515</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandolfi R, et al. Role of acid sphingomyelinase and IL-6 as mediators of endotoxin-induced pulmonary vascular dysfunction. Thorax. 2017;72:460&#x2013;471. doi: 10.1136/thoraxjnl-2015-208067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2015-208067</ArticleId><ArticleId IdType="pubmed">27701117</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkman SA, Tapson VF. COVID-19 and its implications for thrombosis and anticoagulation. Semin. Respir. Crit. Care Med. 2021;42:316&#x2013;326. doi: 10.1055/s-0041-1722992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0041-1722992</ArticleId><ArticleId IdType="pubmed">33548929</ArticleId></ArticleIdList></Reference><Reference><Citation>Grover SP, Mackman N. Tissue factor: an essential mediator of hemostasis and trigger of thrombosis. Arterioscler. Thromb. Vasc. Biol. 2018;38:709&#x2013;725. doi: 10.1161/ATVBAHA.117.309846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.117.309846</ArticleId><ArticleId IdType="pubmed">29437578</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, et al. SARS-CoV-2 infection induces the activation of tissue factor-mediated coagulation via activation of acid sphingomyelinase. Blood. 2021;138:344&#x2013;349. doi: 10.1182/blood.2021010685.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2021010685</ArticleId><ArticleId IdType="pmc">PMC8172270</ArticleId><ArticleId IdType="pubmed">34075401</ArticleId></ArticleIdList></Reference><Reference><Citation>Abusukhun M, et al. Activation of sphingomyelinase-ceramide-pathway in COVID-19 purposes its inhibition for therapeutic strategies. Front. Immunol. 2021;12:784989. doi: 10.3389/fimmu.2021.784989.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.784989</ArticleId><ArticleId IdType="pmc">PMC8721106</ArticleId><ArticleId IdType="pubmed">34987511</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostaza JM, et al. Pre-infection HDL-cholesterol levels and mortality among elderly patients infected with SARS-CoV-2. Atherosclerosis. 2022;341:13&#x2013;19. doi: 10.1016/j.atherosclerosis.2021.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2021.12.009</ArticleId><ArticleId IdType="pmc">PMC8692242</ArticleId><ArticleId IdType="pubmed">34959204</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilser JR, et al. Association of serum HDL-cholesterol and apolipoprotein A1 levels with risk of severe SARS-CoV-2 infection. J. Lipid Res. 2021;62:100061. doi: 10.1016/j.jlr.2021.100061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jlr.2021.100061</ArticleId><ArticleId IdType="pmc">PMC7923911</ArticleId><ArticleId IdType="pubmed">33667465</ArticleId></ArticleIdList></Reference><Reference><Citation>Masana L, et al. Low HDL and high triglycerides predict COVID-19 severity. Sci. Rep. 2021;11:7217. doi: 10.1038/s41598-021-86747-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-86747-5</ArticleId><ArticleId IdType="pmc">PMC8010012</ArticleId><ArticleId IdType="pubmed">33785815</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng F, Lei S, Zhang Q, Zhong Y, Wu S. Triglyceride/high-density lipoprotein cholesterol ratio is associated with the mortality of COVID-19: a retrospective study in China. Int. J. Gen. Med. 2022;15:985&#x2013;996. doi: 10.2147/IJGM.S346690.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S346690</ArticleId><ArticleId IdType="pmc">PMC8815778</ArticleId><ArticleId IdType="pubmed">35136352</ArticleId></ArticleIdList></Reference><Reference><Citation>Groenen AG, Halmos B, Tall AR, Westerterp M. Cholesterol efflux pathways, inflammation, and atherosclerosis. Crit. Rev. Biochem. Mol. Biol. 2021;56:426&#x2013;439. doi: 10.1080/10409238.2021.1925217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10409238.2021.1925217</ArticleId><ArticleId IdType="pmc">PMC9007272</ArticleId><ArticleId IdType="pubmed">34182846</ArticleId></ArticleIdList></Reference><Reference><Citation>Tall AR, Yvan-Charvet L. Cholesterol, inflammation and innate immunity. Nat. Rev. Immunol. 2015;15:104&#x2013;116. doi: 10.1038/nri3793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3793</ArticleId><ArticleId IdType="pmc">PMC4669071</ArticleId><ArticleId IdType="pubmed">25614320</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Roche M, et al. Trafficking of cholesterol to the ER is required for NLRP3 inflammasome activation. J. Cell Biol. 2018;217:3560&#x2013;3576. doi: 10.1083/jcb.201709057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201709057</ArticleId><ArticleId IdType="pmc">PMC6168277</ArticleId><ArticleId IdType="pubmed">30054450</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int. J. Mol. Sci. 2019;20:3328. doi: 10.3390/ijms20133328.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20133328</ArticleId><ArticleId IdType="pmc">PMC6651423</ArticleId><ArticleId IdType="pubmed">31284572</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardoso D, Perucha E. Cholesterol metabolism: a new molecular switch to control inflammation. Clin. Sci. 2021;135:1389&#x2013;1408. doi: 10.1042/CS20201394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20201394</ArticleId><ArticleId IdType="pmc">PMC8187928</ArticleId><ArticleId IdType="pubmed">34086048</ArticleId></ArticleIdList></Reference><Reference><Citation>Radhakrishnan A, Goldstein JL, McDonald JG, Brown MS. Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol: a delicate balance. Cell Metab. 2008;8:512&#x2013;521. doi: 10.1016/j.cmet.2008.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2008.10.008</ArticleId><ArticleId IdType="pmc">PMC2652870</ArticleId><ArticleId IdType="pubmed">19041766</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo C, et al. Cholesterol homeostatic regulator SCAP-SREBP2 integrates NLRP3 inflammasome activation and cholesterol biosynthetic signaling in macrophages. Immunity. 2018;49:842&#x2013;856.e847. doi: 10.1016/j.immuni.2018.08.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2018.08.021</ArticleId><ArticleId IdType="pubmed">30366764</ArticleId></ArticleIdList></Reference><Reference><Citation>Li LC, et al. Cross-talk between TLR4-MyD88-NF-kappaB and SCAP-SREBP2 pathways mediates macrophage foam cell formation. Am. J. Physiol. Heart Circ. Physiol. 2013;304:H874&#x2013;H884. doi: 10.1152/ajpheart.00096.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00096.2012</ArticleId><ArticleId IdType="pubmed">23335792</ArticleId></ArticleIdList></Reference><Reference><Citation>Kusnadi A, et al. The cytokine TNF promotes transcription factor SREBP activity and binding to inflammatory genes to activate macrophages and limit tissue repair. Immunity. 2019;51:241&#x2013;257.e249. doi: 10.1016/j.immuni.2019.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2019.06.005</ArticleId><ArticleId IdType="pmc">PMC6709581</ArticleId><ArticleId IdType="pubmed">31303399</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee W, et al. COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm. Signal Transduct. Target. Ther. 2020;5:186. doi: 10.1038/s41392-020-00292-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00292-7</ArticleId><ArticleId IdType="pmc">PMC7471497</ArticleId><ArticleId IdType="pubmed">32883951</ArticleId></ArticleIdList></Reference><Reference><Citation>Navab M, Anantharamaiah GM, Fogelman AM. The role of high-density lipoprotein in inflammation. Trends Cardiovasc. Med. 2005;15:158&#x2013;161. doi: 10.1016/j.tcm.2005.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2005.05.008</ArticleId><ArticleId IdType="pubmed">16099381</ArticleId></ArticleIdList></Reference><Reference><Citation>Samadi S, et al. Human T lymphotropic virus type 1 and risk of cardiovascular disease: high-density lipoprotein dysfunction versus serum HDL-C concentrations. Biofactors. 2019;45:374&#x2013;380. doi: 10.1002/biof.1489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.1489</ArticleId><ArticleId IdType="pmc">PMC6548577</ArticleId><ArticleId IdType="pubmed">30693992</ArticleId></ArticleIdList></Reference><Reference><Citation>Meilhac O, Tanaka S, Couret D. High-density lipoproteins are bug scavengers. Biomolecules. 2020;10:598. doi: 10.3390/biom10040598.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom10040598</ArticleId><ArticleId IdType="pmc">PMC7226336</ArticleId><ArticleId IdType="pubmed">32290632</ArticleId></ArticleIdList></Reference><Reference><Citation>Stasi A, et al. Multifaced roles of HDL in sepsis and SARS-CoV-2 infection: renal implications. Int. J. Mol. Sci. 2021;22:5980. doi: 10.3390/ijms22115980.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22115980</ArticleId><ArticleId IdType="pmc">PMC8197836</ArticleId><ArticleId IdType="pubmed">34205975</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao YD, et al. Risk factors for severe and critically ill COVID-19 patients: a review. Allergy. 2021;76:428&#x2013;455. doi: 10.1111/all.14657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14657</ArticleId><ArticleId IdType="pubmed">33185910</ArticleId></ArticleIdList></Reference><Reference><Citation>Chea N, et al. Risk factors for SARS-CoV-2 infection among US healthcare personnel, May-December 2020. Emerg. Infect. Dis. 2022;28:95&#x2013;103. doi: 10.3201/eid2801.211803.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2801.211803</ArticleId><ArticleId IdType="pmc">PMC8714235</ArticleId><ArticleId IdType="pubmed">34856114</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu CT, et al. SARS-CoV-2 infects human pancreatic beta cells and elicits beta cell impairment. Cell Metab. 2021;33:1565&#x2013;1576 e1565. doi: 10.1016/j.cmet.2021.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2021.05.013</ArticleId><ArticleId IdType="pmc">PMC8130512</ArticleId><ArticleId IdType="pubmed">34081912</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaharuddin SH, et al. Deleterious effects of SARS-CoV-2 infection on human pancreatic cells. Front. Cell Infect. Microbiol. 2021;11:678482. doi: 10.3389/fcimb.2021.678482.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.678482</ArticleId><ArticleId IdType="pmc">PMC8285288</ArticleId><ArticleId IdType="pubmed">34282405</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F, et al. ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection. Clin. Gastroenterol. Hepatol. 2020;18:2128&#x2013;2130.e2122. doi: 10.1016/j.cgh.2020.04.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2020.04.040</ArticleId><ArticleId IdType="pmc">PMC7194639</ArticleId><ArticleId IdType="pubmed">32334082</ArticleId></ArticleIdList></Reference><Reference><Citation>Khunti K, et al. COVID-19, hyperglycemia, and new-onset diabetes. Diabetes Care. 2021;44:2645&#x2013;2655. doi: 10.2337/dc21-1318.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc21-1318</ArticleId><ArticleId IdType="pmc">PMC8669536</ArticleId><ArticleId IdType="pubmed">34625431</ArticleId></ArticleIdList></Reference><Reference><Citation>Donath MY, Dinarello CA, Mandrup-Poulsen T. Targeting innate immune mediators in type 1 and type 2 diabetes. Nat. Rev. Immunol. 2019;19:734&#x2013;746. doi: 10.1038/s41577-019-0213-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-019-0213-9</ArticleId><ArticleId IdType="pubmed">31501536</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito K, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002;106:2067&#x2013;2072. doi: 10.1161/01.CIR.0000034509.14906.AE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000034509.14906.AE</ArticleId><ArticleId IdType="pubmed">12379575</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu R, Xia CQ, Butfiloski E, Clare-Salzler M. Effect of high glucose on cytokine production by human peripheral blood immune cells and type I interferon signaling in monocytes: Implications for the role of hyperglycemia in the diabetes inflammatory process and host defense against infection. Clin. Immunol. 2018;195:139&#x2013;148. doi: 10.1016/j.clim.2018.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2018.06.003</ArticleId><ArticleId IdType="pmc">PMC6119493</ArticleId><ArticleId IdType="pubmed">29894743</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W, et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab. Res. Rev. 2020;36:e3319. doi: 10.1002/dmrr.3319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dmrr.3319</ArticleId><ArticleId IdType="pmc">PMC7228407</ArticleId><ArticleId IdType="pubmed">32233013</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn WJ, 3rd, et al. Lactate limits T cell proliferation via the NAD(H) redox state. Cell Rep. 2020;33:108500. doi: 10.1016/j.celrep.2020.108500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108500</ArticleId><ArticleId IdType="pmc">PMC7830708</ArticleId><ArticleId IdType="pubmed">33326785</ArticleId></ArticleIdList></Reference><Reference><Citation>Manosalva C, et al. Role of lactate in inflammatory processes: friend or foe. Front. Immunol. 2021;12:808799. doi: 10.3389/fimmu.2021.808799.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.808799</ArticleId><ArticleId IdType="pmc">PMC8795514</ArticleId><ArticleId IdType="pubmed">35095895</ArticleId></ArticleIdList></Reference><Reference><Citation>Pucino V, et al. Lactate buildup at the site of chronic inflammation promotes disease by inducing CD4(+) T cell metabolic rewiring. Cell Metab. 2019;30:1055&#x2013;1074.e1058. doi: 10.1016/j.cmet.2019.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2019.10.004</ArticleId><ArticleId IdType="pmc">PMC6899510</ArticleId><ArticleId IdType="pubmed">31708446</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivashkiv LB. The hypoxia-lactate axis tempers inflammation. Nat. Rev. Immunol. 2020;20:85&#x2013;86. doi: 10.1038/s41577-019-0259-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-019-0259-8</ArticleId><ArticleId IdType="pmc">PMC7021227</ArticleId><ArticleId IdType="pubmed">31819164</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpene G, et al. Blood lactate concentration in COVID-19: a systematic literature review. Clin. Chem. Lab. Med. 2022;60:332&#x2013;337. doi: 10.1515/cclm-2021-1115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2021-1115</ArticleId><ArticleId IdType="pubmed">34856090</ArticleId></ArticleIdList></Reference><Reference><Citation>Battaglini D, Lopes-Pacheco M, Castro-Faria-Neto HC, Pelosi P, Rocco PRM. Laboratory biomarkers for diagnosis and prognosis in COVID-19. Front. Immunol. 2022;13:857573. doi: 10.3389/fimmu.2022.857573.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.857573</ArticleId><ArticleId IdType="pmc">PMC9091347</ArticleId><ArticleId IdType="pubmed">35572561</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang W, et al. Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19. JAMA Intern. Med. 2020;180:1081&#x2013;1089. doi: 10.1001/jamainternmed.2020.2033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.2033</ArticleId><ArticleId IdType="pmc">PMC7218676</ArticleId><ArticleId IdType="pubmed">32396163</ArticleId></ArticleIdList></Reference><Reference><Citation>Zabczyk M, et al. Elevated lactate levels in acute pulmonary embolism are associated with prothrombotic fibrin clot properties: contribution of NETs formation. J. Clin. Med. 2020;9:953. doi: 10.3390/jcm9040953.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9040953</ArticleId><ArticleId IdType="pmc">PMC7231195</ArticleId><ArticleId IdType="pubmed">32235490</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S, et al. Virus-induced senescence is a driver and therapeutic target in COVID-19. Nature. 2021;599:283&#x2013;289. doi: 10.1038/s41586-021-03995-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03995-1</ArticleId><ArticleId IdType="pubmed">34517409</ArticleId></ArticleIdList></Reference><Reference><Citation>Colegio OR, et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature. 2014;513:559&#x2013;563. doi: 10.1038/nature13490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13490</ArticleId><ArticleId IdType="pmc">PMC4301845</ArticleId><ArticleId IdType="pubmed">25043024</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozlov AM, Lone A, Betts DH, Cumming RC. Lactate preconditioning promotes a HIF-1alpha-mediated metabolic shift from OXPHOS to glycolysis in normal human diploid fibroblasts. Sci. Rep. 2020;10:8388. doi: 10.1038/s41598-020-65193-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-65193-9</ArticleId><ArticleId IdType="pmc">PMC7239882</ArticleId><ArticleId IdType="pubmed">32433492</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, et al. Lactate is a natural suppressor of RLR signaling by targeting MAVS. Cell. 2019;178:176&#x2013;189.e115. doi: 10.1016/j.cell.2019.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.05.003</ArticleId><ArticleId IdType="pmc">PMC6625351</ArticleId><ArticleId IdType="pubmed">31155231</ArticleId></ArticleIdList></Reference><Reference><Citation>Gevers D, et al. The treatment-naive microbiome in new-onset Crohn&#x2019;s disease. Cell Host Microbe. 2014;15:382&#x2013;392. doi: 10.1016/j.chom.2014.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2014.02.005</ArticleId><ArticleId IdType="pmc">PMC4059512</ArticleId><ArticleId IdType="pubmed">24629344</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto EA, Jorgensen TN. Relationships between vitamin D, gut microbiome, and systemic autoimmunity. Front. Immunol. 2019;10:3141. doi: 10.3389/fimmu.2019.03141.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.03141</ArticleId><ArticleId IdType="pmc">PMC6985452</ArticleId><ArticleId IdType="pubmed">32038645</ArticleId></ArticleIdList></Reference><Reference><Citation>Schirmer M, et al. Linking the human gut microbiome to inflammatory cytokine production capacity. Cell. 2016;167:1125&#x2013;1136.e1128. doi: 10.1016/j.cell.2016.10.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.10.020</ArticleId><ArticleId IdType="pmc">PMC5131922</ArticleId><ArticleId IdType="pubmed">27814509</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. 2020;159:944. doi: 10.1053/j.gastro.2020.05.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazan S, et al. Lost microbes of COVID-19: Bifidobacterium, Faecalibacterium depletion and decreased microbiome diversity associated with SARS-CoV-2 infection severity. BMJ Open Gastroenterol. 2022;9:e000871. doi: 10.1136/bmjgast-2022-000871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgast-2022-000871</ArticleId><ArticleId IdType="pmc">PMC9051551</ArticleId><ArticleId IdType="pubmed">35483736</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh YK, et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70:698&#x2013;706. doi: 10.1136/gutjnl-2020-323020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes DL, et al. Post-COVID-19 symptom burden: what is long-COVID and how should we manage it? Lung. 2021;199:113&#x2013;119. doi: 10.1007/s00408-021-00423-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00423-z</ArticleId><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechner-Scott J, Levy M, Hawkes C, Yeh A, Giovannoni G. Long COVID or post COVID-19 syndrome. Mult. Scler. Relat. Disord. 2021;55:103268. doi: 10.1016/j.msard.2021.103268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2021.103268</ArticleId><ArticleId IdType="pmc">PMC8447548</ArticleId><ArticleId IdType="pubmed">34601388</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira-Junior AS, et al. Detection of intestinal dysbiosis in post-COVID-19 patients one to eight months after acute disease resolution. Int. J. Environ. Res. Public Health. 2022;19:10189. doi: 10.3390/ijerph191610189.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191610189</ArticleId><ArticleId IdType="pmc">PMC9408204</ArticleId><ArticleId IdType="pubmed">36011823</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022;71:544&#x2013;552. doi: 10.1136/gutjnl-2021-325989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Rishi P, et al. Diet, Gut Microbiota and COVID-19. Indian J. Microbiol. 2020;60:420&#x2013;429. doi: 10.1007/s12088-020-00908-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12088-020-00908-0</ArticleId><ArticleId IdType="pmc">PMC7521193</ArticleId><ArticleId IdType="pubmed">33012868</ArticleId></ArticleIdList></Reference><Reference><Citation>Calder PC. Nutrition, immunity and COVID-19. BMJ Nutr. Prev. Health. 2020;3:74&#x2013;92. doi: 10.1136/bmjnph-2020-000085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjnph-2020-000085</ArticleId><ArticleId IdType="pmc">PMC7295866</ArticleId><ArticleId IdType="pubmed">33230497</ArticleId></ArticleIdList></Reference><Reference><Citation>Jabczyk M, Nowak J, Hudzik B, Zubelewicz-Szkodzinska B. Diet, probiotics and their impact on the gut microbiota during the COVID-19 pandemic. Nutrients. 2021;13:3172. doi: 10.3390/nu13093172.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13093172</ArticleId><ArticleId IdType="pmc">PMC8465654</ArticleId><ArticleId IdType="pubmed">34579048</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberca GGF, Alberca RW. Nutrition and the microbiota post-COVID-19. Saudi. J. Gastroenterol. 2021;27:111&#x2013;112. doi: 10.4103/sjg.sjg_75_21.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/sjg.sjg_75_21</ArticleId><ArticleId IdType="pmc">PMC8183363</ArticleId><ArticleId IdType="pubmed">33835053</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettigrew MM, Tanner W, Harris AD. The lung microbiome and pneumonia. J. Infect. Dis. 2021;223:S241&#x2013;S245. doi: 10.1093/infdis/jiaa702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa702</ArticleId><ArticleId IdType="pubmed">33330898</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumas A, Bernard L, Poquet Y, Lugo-Villarino G, Neyrolles O. The role of the lung microbiota and the gut-lung axis in respiratory infectious diseases. Cell Microbiol. 2018;20:e12966. doi: 10.1111/cmi.12966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cmi.12966</ArticleId><ArticleId IdType="pubmed">30329198</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: a systematic review and meta-analysis. Brain Behav. Immun. 2022;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Holdsworth DA, et al. Comprehensive clinical assessment identifies specific neurocognitive deficits in working-age patients with long-COVID. PLoS ONE. 2022;17:e0267392. doi: 10.1371/journal.pone.0267392.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0267392</ArticleId><ArticleId IdType="pmc">PMC9187094</ArticleId><ArticleId IdType="pubmed">35687603</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo MS, et al. Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Commun. 2020;2:fcaa205. doi: 10.1093/braincomms/fcaa205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa205</ArticleId><ArticleId IdType="pmc">PMC7717144</ArticleId><ArticleId IdType="pubmed">33376990</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Bluemke DA, Luscher TF, Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur. Heart J. 2022;43:1157&#x2013;1172. doi: 10.1093/eurheartj/ehac031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat. Immunol. 2022;23:194&#x2013;202. doi: 10.1038/s41590-021-01104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: an overview. Diabetes Metab. Syndr. 2021;15:869&#x2013;875. doi: 10.1016/j.dsx.2021.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D, et al. Pathophysiology and mechanism of long COVID: a comprehensive review. Ann. Med. 2022;54:1473&#x2013;1487. doi: 10.1080/07853890.2022.2076901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul BD, Lemle MD, Komaroff AL, Snyder SH. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proc. Natl Acad. Sci. USA. 2021;118:e2024358118. doi: 10.1073/pnas.2024358118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2024358118</ArticleId><ArticleId IdType="pmc">PMC8403932</ArticleId><ArticleId IdType="pubmed">34400495</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong TL, Weitzer DJ. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Comparison of Clinical Presentation and Symptomatology. Med. (Kaunas.) 2021;57:418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J, et al. Effect of Dietary Coenzyme Q10 Plus NADH Supplementation on Fatigue Perception and Health-Related Quality of Life in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2021;13:2658. doi: 10.3390/nu13082658.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13082658</ArticleId><ArticleId IdType="pmc">PMC8399248</ArticleId><ArticleId IdType="pubmed">34444817</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock LB, et al. Mast cell activation symptoms are prevalent in Long-COVID. Int. J. Infect. Dis. 2021;112:217&#x2013;226. doi: 10.1016/j.ijid.2021.09.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.09.043</ArticleId><ArticleId IdType="pmc">PMC8459548</ArticleId><ArticleId IdType="pubmed">34563706</ArticleId></ArticleIdList></Reference><Reference><Citation>Wechsler JB, Butuci M, Wong A, Kamboj AP, Youngblood BA. Mast cell activation is associated with post-acute COVID-19 syndrome. Allergy. 2022;77:1288&#x2013;1291. doi: 10.1111/all.15188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15188</ArticleId><ArticleId IdType="pmc">PMC9299596</ArticleId><ArticleId IdType="pubmed">34820848</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto MD, et al. Antihistamines for postacute sequelae of SARS-CoV-2 infection. J. Nurse Pract. 2022;18:335&#x2013;338. doi: 10.1016/j.nurpra.2021.12.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nurpra.2021.12.016</ArticleId><ArticleId IdType="pmc">PMC8820139</ArticleId><ArticleId IdType="pubmed">35153633</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynne P, Tahmasebi N, Gant V, Gupta R. Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines. J. Investig. Med. 2022;70:61&#x2013;67. doi: 10.1136/jim-2021-002051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2021-002051</ArticleId><ArticleId IdType="pmc">PMC8494538</ArticleId><ArticleId IdType="pubmed">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>Bardelcikova A, Mirossay A, Soltys J, Mojzis J. Therapeutic and prophylactic effect of flavonoids in post-COVID-19 therapy. Phytother. Res. 2022;36:2042&#x2013;2060. doi: 10.1002/ptr.7436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.7436</ArticleId><ArticleId IdType="pmc">PMC9111001</ArticleId><ArticleId IdType="pubmed">35302260</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright J, Astill SL, Sivan M. The relationship between physical activity and long COVID: a cross-sectional study. Int. J. Environ. Res. Public. Health. 2022;19:5093. doi: 10.3390/ijerph19095093.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19095093</ArticleId><ArticleId IdType="pmc">PMC9105041</ArticleId><ArticleId IdType="pubmed">35564488</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, et al. Long COVID: the nature of thrombotic sequelae determines the necessity of early anticoagulation. Front. Cell Infect. Microbiol. 2022;12:861703. doi: 10.3389/fcimb.2022.861703.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.861703</ArticleId><ArticleId IdType="pmc">PMC9016198</ArticleId><ArticleId IdType="pubmed">35449732</ArticleId></ArticleIdList></Reference><Reference><Citation>Comelli A, et al. Patient-Reported Symptoms and Sequelae 12 Months After COVID-19 in Hospitalized Adults: A Multicenter Long-Term Follow-Up Study. Front. Med. 2022;9:834354. doi: 10.3389/fmed.2022.834354.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.834354</ArticleId><ArticleId IdType="pmc">PMC8981315</ArticleId><ArticleId IdType="pubmed">35391879</ArticleId></ArticleIdList></Reference><Reference><Citation>Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. Br. Med. J. 2003;326:1423&#x2013;1427. doi: 10.1136/bmj.326.7404.1423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.326.7404.1423</ArticleId><ArticleId IdType="pmc">PMC162260</ArticleId><ArticleId IdType="pubmed">12829554</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang W, Hu JW, He XR, Jin WL, He XY. Statins: a repurposed drug to fight cancer. J. Exp. Clin. Cancer Res. 2021;40:241. doi: 10.1186/s13046-021-02041-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13046-021-02041-2</ArticleId><ArticleId IdType="pmc">PMC8306262</ArticleId><ArticleId IdType="pubmed">34303383</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan J, et al. Letter to the Editor: Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019. Metabolism. 2020;107:154243. doi: 10.1016/j.metabol.2020.154243.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2020.154243</ArticleId><ArticleId IdType="pmc">PMC7166305</ArticleId><ArticleId IdType="pubmed">32320740</ArticleId></ArticleIdList></Reference><Reference><Citation>Oesterle A, Laufs U, Liao JK. Pleiotropic effects of statins on the cardiovascular system. Circ. Res. 2017;120:229&#x2013;243. doi: 10.1161/CIRCRESAHA.116.308537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.116.308537</ArticleId><ArticleId IdType="pmc">PMC5467317</ArticleId><ArticleId IdType="pubmed">28057795</ArticleId></ArticleIdList></Reference><Reference><Citation>McAuley DF, et al. Simvastatin in the acute respiratory distress syndrome. N. Engl. J. Med. 2014;371:1695&#x2013;1703. doi: 10.1056/NEJMoa1403285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1403285</ArticleId><ArticleId IdType="pubmed">25268516</ArticleId></ArticleIdList></Reference><Reference><Citation>Truwit JD, et al. Rosuvastatin for sepsis-associated acute respiratory distress syndrome. N. Engl. J. Med. 2014;370:2191&#x2013;2200. doi: 10.1056/NEJMoa1401520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1401520</ArticleId><ArticleId IdType="pmc">PMC4241052</ArticleId><ArticleId IdType="pubmed">24835849</ArticleId></ArticleIdList></Reference><Reference><Citation>Parihar SP, Guler R, Brombacher F. Statins: a viable candidate for host-directed therapy against infectious diseases. Nat. Rev. Immunol. 2019;19:104&#x2013;117. doi: 10.1038/s41577-018-0094-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-018-0094-3</ArticleId><ArticleId IdType="pubmed">30487528</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Y. Efficacy of statin therapy in patients with acute respiratory distress syndrome_acute lung injury. Eur. Rev. Med. Pharmacol. Sci. 2018;22:3190&#x2013;3198.</Citation><ArticleIdList><ArticleId IdType="pubmed">29863265</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang XJ, et al. In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19. Cell Mateb. 2020;32:176&#x2013;187.e174. doi: 10.1016/j.cmet.2020.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.06.015</ArticleId><ArticleId IdType="pmc">PMC7311917</ArticleId><ArticleId IdType="pubmed">32592657</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Nava G, et al. Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU: a retrospective cohort study. Crit. Care. 2020;24:429. doi: 10.1186/s13054-020-03154-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03154-4</ArticleId><ArticleId IdType="pmc">PMC7358561</ArticleId><ArticleId IdType="pubmed">32664990</ArticleId></ArticleIdList></Reference><Reference><Citation>Yetmar ZA, et al. Prior statin use and risk of mortality and severe disease from coronavirus disease 2019: a systematic review and meta-analysis. Open Forum Infect. Dis. 2021;8:ofab284. doi: 10.1093/ofid/ofab284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab284</ArticleId><ArticleId IdType="pmc">PMC8244756</ArticleId><ArticleId IdType="pubmed">34258316</ArticleId></ArticleIdList></Reference><Reference><Citation>Hariyanto TI, Kurniawan A. Statin therapy did not improve the in-hospital outcome of coronavirus disease 2019 (COVID-19) infection. Int. J. Diabetes Metab. Syndr. 2020;14:1613&#x2013;1615. doi: 10.1016/j.dsx.2020.08.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.08.023</ArticleId><ArticleId IdType="pmc">PMC7448951</ArticleId><ArticleId IdType="pubmed">32882643</ArticleId></ArticleIdList></Reference><Reference><Citation>Tikoo K, et al. Tissue specific up regulation of ACE2 in rabbit model of atherosclerosis by atorvastatin: role of epigenetic histone modifications. Biochem. Pharm. 2015;93:343&#x2013;351. doi: 10.1016/j.bcp.2014.11.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2014.11.013</ArticleId><ArticleId IdType="pubmed">25482567</ArticleId></ArticleIdList></Reference><Reference><Citation>Kornhuber J, Tripal P, Gulbins E, Muehlbacher M. Functional inhibitors of acid sphingomyelinase (FIASMAs) Handb. Exp. Pharm. 2013;215:169&#x2013;186. doi: 10.1007/978-3-7091-1368-4_9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-7091-1368-4_9</ArticleId><ArticleId IdType="pubmed">23579455</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhemkov V, et al. The role of sigma 1 receptor in organization of endoplasmic reticulum signaling microdomains. Elife. 2021;10:e65192. doi: 10.7554/eLife.65192.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.65192</ArticleId><ArticleId IdType="pmc">PMC8112866</ArticleId><ArticleId IdType="pubmed">33973848</ArticleId></ArticleIdList></Reference><Reference><Citation>Vela JM. Repurposing Sigma-1 Receptor Ligands for COVID-19 Therapy? Front. Pharmacol. 2020;11:582310. doi: 10.3389/fphar.2020.582310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.582310</ArticleId><ArticleId IdType="pmc">PMC7751758</ArticleId><ArticleId IdType="pubmed">33364957</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishima T, Fujita Y, Hashimoto K. Interaction of new antidepressants with sigma-1 receptor chaperones and their potentiation of neurite outgrowth in PC12 cells. Eur. J. Pharmacol. 2014;727:167&#x2013;173. doi: 10.1016/j.ejphar.2014.01.064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2014.01.064</ArticleId><ArticleId IdType="pubmed">24508523</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoertel N, et al. Association Between FIASMAs and Reduced Risk of Intubation or Death in Individuals Hospitalized for Severe COVID-19: An Observational Multicenter Study. Clin. Pharmacol. Ther. 2021;110:1498&#x2013;1511. doi: 10.1002/cpt.2317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpt.2317</ArticleId><ArticleId IdType="pmc">PMC8239599</ArticleId><ArticleId IdType="pubmed">34050932</ArticleId></ArticleIdList></Reference><Reference><Citation>Darquennes G, Le Corre P, Le Moine O, Loas G. Association between Functional Inhibitors of Acid Sphingomyelinase (FIASMAs) and Reduced Risk of Death in COVID-19 Patients: A Retrospective Cohort Study. Pharmaceuticals. 2021;14:226. doi: 10.3390/ph14030226.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph14030226</ArticleId><ArticleId IdType="pmc">PMC7998809</ArticleId><ArticleId IdType="pubmed">33799977</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenze EJ, et al. Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial. JAMA. 2020;324:2292&#x2013;2300. doi: 10.1001/jama.2020.22760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.22760</ArticleId><ArticleId IdType="pmc">PMC7662481</ArticleId><ArticleId IdType="pubmed">33180097</ArticleId></ArticleIdList></Reference><Reference><Citation>Reis G, et al. Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial. Lancet Glob. Health. 2022;10:E36&#x2013;E45. doi: 10.1016/S2214-109X(21)00448-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(21)00448-4</ArticleId><ArticleId IdType="pmc">PMC8550952</ArticleId><ArticleId IdType="pubmed">34717820</ArticleId></ArticleIdList></Reference><Reference><Citation>Freites Nunez DD, et al. Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases. Ann. Rheum. Dis. 2020;79:1393&#x2013;1399. doi: 10.1136/annrheumdis-2020-217984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-217984</ArticleId><ArticleId IdType="pubmed">32769150</ArticleId></ArticleIdList></Reference><Reference><Citation>Rentsch, C. T. et al. Covid-19 testing, hospital admission, and intensive care among 2,026,227 United States Veterans aged 54-75 years. Preprint at medRxiv10.1101/2020.04.09.20059964 (2020).</Citation></Reference><Reference><Citation>de Bruin N, et al. Ibuprofen, flurbiprofen, etoricoxib or paracetamol do not influence ACE2 expression and activity in vitro or in mice and do not exacerbate in-vitro SARS-CoV-2 infection. Int. J. Mol. Sci. 2022;23:1049. doi: 10.3390/ijms23031049.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23031049</ArticleId><ArticleId IdType="pmc">PMC8835123</ArticleId><ArticleId IdType="pubmed">35162972</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JS, et al. Non-steroidal anti-inflammatory drugs dampen the cytokine and antibody response to SARS-CoV-2 infection. J. Virol. 2021;95:e00014&#x2013;e00021. doi: 10.1128/JVI.00014-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00014-21</ArticleId><ArticleId IdType="pmc">PMC8092681</ArticleId><ArticleId IdType="pubmed">33441348</ArticleId></ArticleIdList></Reference><Reference><Citation>Sodhi M, Etminan M. Safety of ibuprofen in patients with COVID-19: causal or confounded? Chest. 2020;158:55&#x2013;56. doi: 10.1016/j.chest.2020.03.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2020.03.040</ArticleId><ArticleId IdType="pmc">PMC7151542</ArticleId><ArticleId IdType="pubmed">32243944</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore N, Bosco-Levy P, Thurin N, Blin P, Droz-Perroteau C. NSAIDs and COVID-19: a systematic review and meta-analysis. Drug Saf. 2021;44:929&#x2013;938. doi: 10.1007/s40264-021-01089-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40264-021-01089-5</ArticleId><ArticleId IdType="pmc">PMC8327046</ArticleId><ArticleId IdType="pubmed">34339037</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt M, et al. Non-steroidal anti-inflammatory drug use and risk of venous thromboembolism. J. Thromb. Haemost. 2011;9:1326&#x2013;1333. doi: 10.1111/j.1538-7836.2011.04354.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2011.04354.x</ArticleId><ArticleId IdType="pubmed">21592304</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabausch K, et al. Regulation of thrombomodulin expression in human vascular smooth muscle cells by COX-2-derived prostaglandins. Circ. Res. 2005;96:e1&#x2013;e6. doi: 10.1161/01.RES.0000153150.27690.f2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.RES.0000153150.27690.f2</ArticleId><ArticleId IdType="pubmed">15591227</ArticleId></ArticleIdList></Reference><Reference><Citation>FitzGerald GA. Misguided drug advice for COVID-19. Science. 2020;367:1434. doi: 10.1126/science.abb8034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb8034</ArticleId><ArticleId IdType="pubmed">32198292</ArticleId></ArticleIdList></Reference><Reference><Citation>Maeba S, et al. Effect of montelukast on nuclear factor kB activation and proinflammatory molecules. Ann. Allergy Asthma Immunol. 2005;94:670&#x2013;674. doi: 10.1016/S1081-1206(10)61326-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1081-1206(10)61326-9</ArticleId><ArticleId IdType="pubmed">15984600</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahan F, Jazrawi E, Moodley T, Rovati GE, Adcock IM. Montelukast inhibits tumour necrosis factor-alpha-mediated interleukin-8 expression through inhibition of nuclear factor-kappaB p65-associated histone acetyltransferase activity. Clin. Exp. Allergy. 2008;38:805&#x2013;811. doi: 10.1111/j.1365-2222.2008.02963.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2222.2008.02963.x</ArticleId><ArticleId IdType="pubmed">18325031</ArticleId></ArticleIdList></Reference><Reference><Citation>Camera M, Canzano P, Brambilla M, Rovati GE. Montelukast inhibits platelet activation induced by plasma from COVID-19 patients. Front. Pharmacol. 2022;13:784214. doi: 10.3389/fphar.2022.784214.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.784214</ArticleId><ArticleId IdType="pmc">PMC8863130</ArticleId><ArticleId IdType="pubmed">35211011</ArticleId></ArticleIdList></Reference><Reference><Citation>Luedemann M, et al. Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposing. Comput. Struct. Biotechnol. J. 2022;20:799&#x2013;811. doi: 10.1016/j.csbj.2022.01.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.csbj.2022.01.024</ArticleId><ArticleId IdType="pmc">PMC8800171</ArticleId><ArticleId IdType="pubmed">35126884</ArticleId></ArticleIdList></Reference><Reference><Citation>Thoms M, et al. Structural basis for translational shutdown and immune evasion by the Nsp1. Science. 2020;369:1249. doi: 10.1126/science.abc8665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc8665</ArticleId><ArticleId IdType="pmc">PMC7402621</ArticleId><ArticleId IdType="pubmed">32680882</ArticleId></ArticleIdList></Reference><Reference><Citation>Afsar M, et al. Drug targeting Nsp1-ribosomal complex shows antiviral activity against SARS-CoV-2. Elife. 2022;11:e74877. doi: 10.7554/eLife.74877.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.74877</ArticleId><ArticleId IdType="pmc">PMC9018067</ArticleId><ArticleId IdType="pubmed">35323109</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan AR, et al. Montelukast in hospitalized patients diagnosed with COVID-19. J. Asthma. 2022;59:780&#x2013;786. doi: 10.1080/02770903.2021.1881967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02770903.2021.1881967</ArticleId><ArticleId IdType="pmc">PMC7938648</ArticleId><ArticleId IdType="pubmed">33577360</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerget B, Kerget F, Aydin M, Karasahin O. Effect of montelukast therapy on clinical course, pulmonary function, and mortality in patients with COVID-19. J. Med. Virol. 2022;94:1950&#x2013;1958. doi: 10.1002/jmv.27552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27552</ArticleId><ArticleId IdType="pmc">PMC9015221</ArticleId><ArticleId IdType="pubmed">34958142</ArticleId></ArticleIdList></Reference><Reference><Citation>Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510:92&#x2013;101. doi: 10.1038/nature13479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13479</ArticleId><ArticleId IdType="pmc">PMC4263681</ArticleId><ArticleId IdType="pubmed">24899309</ArticleId></ArticleIdList></Reference><Reference><Citation>Serhan CN. Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms. Faseb. J. 2017;31:1273&#x2013;1288. doi: 10.1096/fj.201601222R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201601222R</ArticleId><ArticleId IdType="pmc">PMC5349794</ArticleId><ArticleId IdType="pubmed">28087575</ArticleId></ArticleIdList></Reference><Reference><Citation>Regidor PA, Santos FG, Rizo JM, Egea FM. Pro resolving inflammatory effects of the lipid mediators of omega 3 fatty acids and its implication in SARS COVID-19. Med. Hypotheses. 2020;145:110340. doi: 10.1016/j.mehy.2020.110340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110340</ArticleId><ArticleId IdType="pmc">PMC7543931</ArticleId><ArticleId IdType="pubmed">33069094</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez-Santana M, et al. Inverse association between omega-3 index and severity of COVID-19: a case-control study. Int. J. Environ. Res. Public Health. 2022;19:6445. doi: 10.3390/ijerph19116445.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19116445</ArticleId><ArticleId IdType="pmc">PMC9180292</ArticleId><ArticleId IdType="pubmed">35682030</ArticleId></ArticleIdList></Reference><Reference><Citation>Doaei S, et al. The effect of omega-3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID-19: a randomized clinical trial. J. Transl. Med. 2021;19:128. doi: 10.1186/s12967-021-02795-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-02795-5</ArticleId><ArticleId IdType="pmc">PMC8006115</ArticleId><ArticleId IdType="pubmed">33781275</ArticleId></ArticleIdList></Reference><Reference><Citation>Weill P, Plissonneau C, Legrand P, Rioux V, Thibault R. May omega-3 fatty acid dietary supplementation help reduce severe complications in Covid-19 patients? Biochimie. 2020;179:275&#x2013;280. doi: 10.1016/j.biochi.2020.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2020.09.003</ArticleId><ArticleId IdType="pmc">PMC7481803</ArticleId><ArticleId IdType="pubmed">32920170</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesri EA, Lampidis TJ. 2-Deoxy-d-glucose exploits increased glucose metabolism in cancer and viral-infected cells: relevance to its use in India against SARS-CoV-2. IUBMB Life. 2021;73:1198&#x2013;1204. doi: 10.1002/iub.2546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iub.2546</ArticleId><ArticleId IdType="pmc">PMC8653061</ArticleId><ArticleId IdType="pubmed">34418270</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki K, et al. Nanoparticle-mediated delivery of 2-deoxy-d-glucose induces antitumor immunity and cytotoxicity in liver tumors in mice. Cell Mol. Gastroenterol. Hepatol. 2021;11:739&#x2013;762. doi: 10.1016/j.jcmgh.2020.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmgh.2020.10.010</ArticleId><ArticleId IdType="pmc">PMC7841526</ArticleId><ArticleId IdType="pubmed">33191170</ArticleId></ArticleIdList></Reference><Reference><Citation>Rho JM, Shao LR, Stafstrom CE. 2-Deoxyglucose and beta-hydroxybutyrate: metabolic agents for seizure control. Front. Cell Neurosci. 2019;13:172. doi: 10.3389/fncel.2019.00172.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00172</ArticleId><ArticleId IdType="pmc">PMC6503754</ArticleId><ArticleId IdType="pubmed">31114484</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatt AN, et al. Glycolytic inhibitor 2-deoxy-D-glucose attenuates SARS-CoV-2 multiplication in host cells. Life Sci. 2021;295:120411. doi: 10.1016/j.lfs.2022.120411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2022.120411</ArticleId><ArticleId IdType="pmc">PMC8847085</ArticleId><ArticleId IdType="pubmed">35181310</ArticleId></ArticleIdList></Reference><Reference><Citation>Dwarakanath BS, Jain V. Targeting glucose metabolism with 2-deoxy-D-glucose for improving cancer therapy. Future Oncol. 2009;5:581&#x2013;585. doi: 10.2217/fon.09.44.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fon.09.44</ArticleId><ArticleId IdType="pubmed">19519197</ArticleId></ArticleIdList></Reference><Reference><Citation>Voss M, et al. Rescue of 2-deoxyglucose side effects by ketogenic diet. Int. J. Mol. Sci. 2018;19:2462. doi: 10.3390/ijms19082462.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19082462</ArticleId><ArticleId IdType="pmc">PMC6121440</ArticleId><ArticleId IdType="pubmed">30127309</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatt AN, et al. 2-Deoxy-D-glucose as an adjunct to standard of care in the medical management of COVID-19: a proof-of-concept and dose-ranging randomised phase II clinical trial. BMC Infect. Dis. 2022;22:669. doi: 10.1186/s12879-022-07642-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07642-6</ArticleId><ArticleId IdType="pmc">PMC9351257</ArticleId><ArticleId IdType="pubmed">35927676</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai B, Chen H. Metformin: a novel weapon against inflammation. Front. Pharmacol. 2021;12:622262. doi: 10.3389/fphar.2021.622262.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.622262</ArticleId><ArticleId IdType="pmc">PMC7880161</ArticleId><ArticleId IdType="pubmed">33584319</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi Y, et al. Metformin promotes AMP-activated protein kinase-independent suppression of delta Np63 alpha protein expression and inhibits cancer cell viability. J. Biol. Chem. 2017;292:5253&#x2013;5261. doi: 10.1074/jbc.M116.769141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M116.769141</ArticleId><ArticleId IdType="pmc">PMC5392672</ArticleId><ArticleId IdType="pubmed">28193839</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi Y, Zhang W, Yi J, Xiao ZX. Role of p53 family proteins in metformin anti-cancer activities. J. Cancer. 2019;10:2434&#x2013;2442. doi: 10.7150/jca.30659.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/jca.30659</ArticleId><ArticleId IdType="pmc">PMC6584340</ArticleId><ArticleId IdType="pubmed">31258748</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Chen B, Feng Q, Nie C, Li T. Clinical perspectives and concerns of metformin as an anti-aging drug. Aging Med. 2020;3:266&#x2013;275. doi: 10.1002/agm2.12135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/agm2.12135</ArticleId><ArticleId IdType="pmc">PMC7771567</ArticleId><ArticleId IdType="pubmed">33392433</ArticleId></ArticleIdList></Reference><Reference><Citation>Khunti K, et al. Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England. Lancet Diabetes Endocrinol. 2021;9:293&#x2013;303. doi: 10.1016/S2213-8587(21)00050-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(21)00050-4</ArticleId><ArticleId IdType="pmc">PMC8009618</ArticleId><ArticleId IdType="pubmed">33798464</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalau JD, et al. Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19. Diabetes Metab. 2021;47:101216. doi: 10.1016/j.diabet.2020.101216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diabet.2020.101216</ArticleId><ArticleId IdType="pmc">PMC7832745</ArticleId><ArticleId IdType="pubmed">33309936</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo P, et al. Metformin treatment was associated with decreased mortality in COVID-19 patients with diabetes in a retrospective analysis. Am. J. Trop. Med. Hyg. 2020;103:69&#x2013;72. doi: 10.4269/ajtmh.20-0375.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.20-0375</ArticleId><ArticleId IdType="pmc">PMC7356425</ArticleId><ArticleId IdType="pubmed">32446312</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, et al. Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication. Diabetes Care. 2020;43:1399&#x2013;1407. doi: 10.2337/dc20-0660.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc20-0660</ArticleId><ArticleId IdType="pubmed">32409498</ArticleId></ArticleIdList></Reference><Reference><Citation>Afshari K, et al. Anti-inflammatory effects of Metformin improve the neuropathic pain and locomotor activity in spinal cord injured rats: introduction of an alternative therapy. Spinal Cord. 2018;56:1032&#x2013;1041. doi: 10.1038/s41393-018-0168-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41393-018-0168-x</ArticleId><ArticleId IdType="pubmed">29959433</ArticleId></ArticleIdList></Reference><Reference><Citation>Jadhav S, et al. Effects of metformin on microvascular function and exercise tolerance in women with angina and normal coronary arteries: a randomized, double-blind, placebo-controlled study. J. Am. Coll. Cardiol. 2006;48:956&#x2013;963. doi: 10.1016/j.jacc.2006.04.088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2006.04.088</ArticleId><ArticleId IdType="pubmed">16949486</ArticleId></ArticleIdList></Reference><Reference><Citation>Ursini F, et al. Metformin and autoimmunity: a &#x201c;new deal&#x201d; of an old drug. Front. Immunol. 2018;9:1236. doi: 10.3389/fimmu.2018.01236.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01236</ArticleId><ArticleId IdType="pmc">PMC5994909</ArticleId><ArticleId IdType="pubmed">29915588</ArticleId></ArticleIdList></Reference><Reference><Citation>Rangarajan S, et al. Metformin reverses established lung fibrosis in a bleomycin model. Nat. Med. 2018;24:1121&#x2013;1127. doi: 10.1038/s41591-018-0087-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0087-6</ArticleId><ArticleId IdType="pmc">PMC6081262</ArticleId><ArticleId IdType="pubmed">29967351</ArticleId></ArticleIdList></Reference><Reference><Citation>Rena G, Hardie DG, Pearson ER. The mechanisms of action of metformin. Diabetologia. 2017;60:1577&#x2013;1585. doi: 10.1007/s00125-017-4342-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-017-4342-z</ArticleId><ArticleId IdType="pmc">PMC5552828</ArticleId><ArticleId IdType="pubmed">28776086</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi KS, Aizaki H, Lai MM. Murine coronavirus requires lipid rafts for virus entry and cell-cell fusion but not for virus release. J. Virol. 2005;79:9862&#x2013;9871. doi: 10.1128/JVI.79.15.9862-9871.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.15.9862-9871.2005</ArticleId><ArticleId IdType="pmc">PMC1181594</ArticleId><ArticleId IdType="pubmed">16014947</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo H, et al. The important role of lipid raft-mediated attachment in the infection of cultured cells by coronavirus infectious bronchitis virus beaudette strain. PLoS ONE. 2017;12:e0170123. doi: 10.1371/journal.pone.0170123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0170123</ArticleId><ArticleId IdType="pmc">PMC5231368</ArticleId><ArticleId IdType="pubmed">28081264</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei X, She G, Wu T, Xue C, Cao Y. PEDV enters cells through clathrin-, caveolae-, and lipid raft-mediated endocytosis and traffics via the endo-/lysosome pathway. Vet. Res. 2020;51:10. doi: 10.1186/s13567-020-0739-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13567-020-0739-7</ArticleId><ArticleId IdType="pmc">PMC7011528</ArticleId><ArticleId IdType="pubmed">32041637</ArticleId></ArticleIdList></Reference><Reference><Citation>Sviridov D, Miller YI, Ballout RA, Remaley AT, Bukrinsky M. Targeting lipid rafts-a potential therapy for COVID-19. Front. Immunol. 2020;11:574508. doi: 10.3389/fimmu.2020.574508.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.574508</ArticleId><ArticleId IdType="pmc">PMC7550455</ArticleId><ArticleId IdType="pubmed">33133090</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R, Wang Q, Yang J. Potential of sphingosine-1-phosphate in preventing SARS-CoV-2 infection by stabilizing and protecting endothelial cells. Medicine. 2022;101:e29164. doi: 10.1097/MD.0000000000029164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000029164</ArticleId><ArticleId IdType="pmc">PMC9276324</ArticleId><ArticleId IdType="pubmed">35475801</ArticleId></ArticleIdList></Reference><Reference><Citation>Maceyka M, Spiegel S. Sphingolipid metabolites in inflammatory disease. Nature. 2014;510:58&#x2013;67. doi: 10.1038/nature13475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13475</ArticleId><ArticleId IdType="pmc">PMC4320971</ArticleId><ArticleId IdType="pubmed">24899305</ArticleId></ArticleIdList></Reference><Reference><Citation>Shulla A, Gallagher T. Role of spike protein endodomains in regulating coronavirus entry. J. Biol. Chem. 2009;284:32725&#x2013;32734. doi: 10.1074/jbc.M109.043547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.043547</ArticleId><ArticleId IdType="pmc">PMC2781689</ArticleId><ArticleId IdType="pubmed">19801669</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang JT, et al. Positive-strand RNA viruses stimulate host phosphatidylcholine synthesis at viral replication sites. Proc. Natl Acad. Sci. USA. 2016;113:E1604&#x2013;E1073.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4776486</ArticleId><ArticleId IdType="pubmed">26858414</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JY, et al. Spatiotemporal coupling of the hepatitis C virus replication cycle by creating a lipid droplet- proximal membranous replication compartment. Cell Rep. 2019;27:3602&#x2013;3617.e3605. doi: 10.1016/j.celrep.2019.05.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.05.063</ArticleId><ArticleId IdType="pubmed">31216478</ArticleId></ArticleIdList></Reference><Reference><Citation>Bang BR, et al. Regulation of hepatitis C virus infection by cellular retinoic acid binding proteins through the modulation of lipid droplet abundance. J. Virol. 2019;93:e02302&#x2013;e02318. doi: 10.1128/JVI.02302-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02302-18</ArticleId><ArticleId IdType="pmc">PMC6450116</ArticleId><ArticleId IdType="pubmed">30728260</ArticleId></ArticleIdList></Reference><Reference><Citation>Criglar JM, Estes MK, Crawford SE. Rotavirus-induced lipid droplet biogenesis is critical for virus replication. Front. Physiol. 2022;13:836870. doi: 10.3389/fphys.2022.836870.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2022.836870</ArticleId><ArticleId IdType="pmc">PMC9040889</ArticleId><ArticleId IdType="pubmed">35492603</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins AS, Martins IC, Santos NC. Methods for lipid droplet biophysical characterization in flaviviridae infections. Front. Microbiol. 2018;9:1951. doi: 10.3389/fmicb.2018.01951.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.01951</ArticleId><ArticleId IdType="pmc">PMC6110928</ArticleId><ArticleId IdType="pubmed">30186265</ArticleId></ArticleIdList></Reference><Reference><Citation>Zandi M, et al. Interplay between cellular metabolism and DNA viruses. J. Med. Virol. 2022;94:5163&#x2013;5173. doi: 10.1002/jmv.28018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28018</ArticleId><ArticleId IdType="pubmed">35869415</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Ramirez I, et al. Regulation of cellular metabolism by high-risk human papillomaviruses. Int. J. Mol. Sci. 2018;19:1839. doi: 10.3390/ijms19071839.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19071839</ArticleId><ArticleId IdType="pmc">PMC6073392</ArticleId><ArticleId IdType="pubmed">29932118</ArticleId></ArticleIdList></Reference><Reference><Citation>Park GJ, et al. The mechanism of RNA capping by SARS-CoV-2. Nature. 2022;609:793&#x2013;800.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9492545</ArticleId><ArticleId IdType="pubmed">35944563</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker AP, et al. The SARS-CoV-2 RNA polymerase is a viral RNA capping enzyme. Nucleic Acids Res. 2021;49:13019&#x2013;13030. doi: 10.1093/nar/gkab1160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab1160</ArticleId><ArticleId IdType="pmc">PMC8682786</ArticleId><ArticleId IdType="pubmed">34850141</ArticleId></ArticleIdList></Reference><Reference><Citation>Bracquemond D, Muriaux D. Betacoronavirus assembly: clues and perspectives for elucidating SARS-CoV-2 particle formation and egress. mBio. 2021;12:e0237121. doi: 10.1128/mBio.02371-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02371-21</ArticleId><ArticleId IdType="pmc">PMC8546641</ArticleId><ArticleId IdType="pubmed">34579570</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Melino G, Shi Y. Actively or passively deacidified lysosomes push beta-coronavirus egress. Cell Death Dis. 2021;12:235. doi: 10.1038/s41419-021-03501-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-021-03501-5</ArticleId><ArticleId IdType="pmc">PMC7930523</ArticleId><ArticleId IdType="pubmed">33664221</ArticleId></ArticleIdList></Reference><Reference><Citation>Henne M. And three&#x2019;s a party: lysosomes, lipid droplets, and the ER in lipid trafficking and cell homeostasis. Curr. Opin. Cell Biol. 2019;59:40&#x2013;49. doi: 10.1016/j.ceb.2019.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceb.2019.02.011</ArticleId><ArticleId IdType="pubmed">31003052</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaishy B, Abel ED. Lipids, lysosomes, and autophagy. J. Lipid Res. 2016;57:1619&#x2013;1635. doi: 10.1194/jlr.R067520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.R067520</ArticleId><ArticleId IdType="pmc">PMC5003162</ArticleId><ArticleId IdType="pubmed">27330054</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Yang CS, Liu Y, Zhang X. Effective regulation of gut microbiota with probiotics and prebiotics may prevent or alleviate COVID-19 through the gut-lung axis. Front. Pharmacol. 2022;13:895193. doi: 10.3389/fphar.2022.895193.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.895193</ArticleId><ArticleId IdType="pmc">PMC9081431</ArticleId><ArticleId IdType="pubmed">35548347</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira GLV, Oliveira CNS, Pinzan CF, de Salis LVV, Cardoso CRB. Microbiota modulation of the gut-lung axis in COVID-19. Front. Immunol. 2021;12:635471. doi: 10.3389/fimmu.2021.635471.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.635471</ArticleId><ArticleId IdType="pmc">PMC7945592</ArticleId><ArticleId IdType="pubmed">33717181</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, et al. COVID-19: gastrointestinal symptoms from the view of gut-lung axis. Eur. J. Gastroenterol. Hepatol. 2021;33:610&#x2013;612. doi: 10.1097/MEG.0000000000001984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MEG.0000000000001984</ArticleId><ArticleId IdType="pubmed">33136724</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>